Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Search

Page Path
HOME > Search
32 "Cholangiocarcinoma"
Filter
Filter
Article category
Keywords
Publication year
Authors
Reviews
Optimal endoscopic drainage strategy for unresectable malignant hilar biliary obstruction
Itaru Naitoh, Tadahisa Inoue
Clin Endosc 2023;56(2):135-142.   Published online January 5, 2023
DOI: https://doi.org/10.5946/ce.2022.150
AbstractAbstract PDFPubReaderePub
Endoscopic biliary drainage strategies for managing unresectable malignant hilar biliary obstruction differ in terms of stent type, drainage area, and deployment method. However, the optimal endoscopic drainage strategy remains unclear. Uncovered self-expandable metal stents (SEMS) are the preferred type because of their higher functional success rate, longer time to recurrent biliary obstruction (RBO), and fewer cases of reintervention than plastic stents (PS). Other PS subtypes and covered SEMS, which feature a longer time to RBO than PS, can be removed during reintervention for RBO. Bilateral SEMS placement is associated with a longer time to RBO and a longer survival time than unilateral SEMS placement. Unilateral drainage is acceptable if a drainage volume of greater than 50% of the total liver volume can be achieved. In terms of deployment method, no differences were observed in clinical outcomes between side-by-side (SBS) and stent-in-stent deployment. Simultaneous SBS boasts a shorter procedure time and higher technical success rate than sequential SBS. This review of previous studies aimed to clarify the optimal endoscopic biliary drainage strategy for unresectable malignant hilar biliary obstruction.

Citations

Citations to this article as recorded by  
  • Comparison of unilateral and bilateral intraductal plastic stent placement for unresectable malignant hilar biliary obstruction: A propensity score‐matched cohort analysis
    Mitsuru Okuno, Keisuke Iwata, Tsuyoshi Mukai, Yuhei Iwasa, Shinya Uemura, Kensaku Yoshida, Akinori Maruta, Takuji Iwashita, Ichiro Yasuda, Masahito Shimizu
    Journal of Hepato-Biliary-Pancreatic Sciences.2024; 31(4): 284.     CrossRef
  • Preoperative endoscopic biliary drainage by metal versus plastic stents for resectable perihilar cholangiocarcinoma
    David M. de Jong, Timothy M. Gilbert, Lynn E. Nooijen, Eva Braunwarth, Marijana Ninkovic, Florian Primavesi, Hassan Z. Malik, Nick Stern, Richard Sturgess, Joris I. Erdmann, Rogier P. Voermans, Marco J. Bruno, Bas Groot Koerkamp, Lydi M.J.W. van Driel
    Gastrointestinal Endoscopy.2024; 99(4): 566.     CrossRef
  • TOKYO criteria 2024 for the assessment of clinical outcomes of endoscopic biliary drainage
    Hiroyuki Isayama, Tsuyoshi Hamada, Toshio Fujisawa, Mitsuharu Fukasawa, Kazuo Hara, Atsushi Irisawa, Shigeto Ishii, Ken Ito, Takao Itoi, Yoshihide Kanno, Akio Katanuma, Hironari Kato, Hiroshi Kawakami, Hirofumi Kawamoto, Masayuki Kitano, Hirofumi Kogure,
    Digestive Endoscopy.2024;[Epub]     CrossRef
  • Trisectoral Metal Stenting Using Combined Stent-by-Stent and Stent-in-Stent Method for Malignant Hilar Biliary Obstruction: A Prospective Pilot Study
    Tadahisa Inoue, Rena Kitano, Mayu Ibusuki, Tomoya Kitada, Kazumasa Sakamoto, Satoshi Kimoto, Jun Arai, Kiyoaki Ito
    Digestive Diseases and Sciences.2024;[Epub]     CrossRef
  • Research progress on biliary stents

    Progress in Medical Devices.2023;[Epub]     CrossRef
  • 3,380 View
  • 338 Download
  • 4 Web of Science
  • 5 Crossref
Close layer
Comparing palliative treatment options for cholangiocarcinoma: photodynamic therapy vs. radiofrequency ablation
Tayyaba Mohammad, Michel Kahaleh
Clin Endosc 2022;55(3):347-354.   Published online May 17, 2022
DOI: https://doi.org/10.5946/ce.2021.274
AbstractAbstract PDFPubReaderePub
Referral to an endoscopist is often done once curative resection is no longer an option for cholangiocarcinoma management. In such cases, palliation has become the main objective of the treatment. Photodynamic therapy and radiofrequency ablation can be performed to achieve palliation, with both procedures associated with improved stent patency and survival. Despite the greatly increased cost and association with photosensitivity, photodynamic therapy allows transmission to the entire biliary tree. In contrast, radiofrequency ablation is cheaper and faster to apply but requires intraductal contact. This paper reviews both modalities and compares their efficacy and safety for bile duct cancer palliation.

Citations

Citations to this article as recorded by  
  • Current interventional options for palliative care for patients with advanced-stage cholangiocarcinoma
    Maryam Makki, Malak Bentaleb, Mohammed Abdulrahman, Amal Abdulla Suhool, Salem Al Harthi, Marcelo AF Ribeiro Jr
    World Journal of Clinical Oncology.2024; 15(3): 381.     CrossRef
  • Endoskopisch gesteuerte Diagnostik und Therapie von Cholangiokarzinomen
    Ulrike Denzer, Alexander Dechêne
    Die Gastroenterologie.2023; 18(1): 16.     CrossRef
  • Recent Updates on Local Ablative Therapy Combined with Chemotherapy for Extrahepatic Cholangiocarcinoma: Photodynamic Therapy and Radiofrequency Ablation
    Tadahisa Inoue, Masashi Yoneda
    Current Oncology.2023; 30(2): 2159.     CrossRef
  • Role of radiofrequency ablation in advanced malignant hilar biliary obstruction
    Mamoru Takenaka, Tae Hoon Lee
    Clinical Endoscopy.2023; 56(2): 155.     CrossRef
  • Impact of endobiliary radiofrequency ablation on survival of patients with unresectable cholangiocarcinoma: a narrative review
    Elena Di Girolamo, Andrea Belli, Alessandro Ottaiano, Vincenza Granata, Valentina Borzillo, Luca Tarotto, Fabiana Tatangelo, Raffaele Palaia, Corrado Civiletti, Mauro Piccirillo, Valentina D’Angelo, Francesco Fiore, Pietro Marone, Guglielmo Nasti, Frances
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Thermal ablative therapies in the gastrointestinal tract
    Hendrik Manner
    Current Opinion in Gastroenterology.2023; 39(5): 370.     CrossRef
  • Photodynamic Therapy: From the Basics to the Current Progress of N-Heterocyclic-Bearing Dyes as Effective Photosensitizers
    Eurico Lima, Lucinda V. Reis
    Molecules.2023; 28(13): 5092.     CrossRef
  • Balloon‐assisted laser application for endoscopic treatment of biliary stricture
    Seonghee Lim, Van Gia Truong, Seok Jeong, Jiho Lee, Byeong‐il Lee, Hyun Wook Kang
    Lasers in Surgery and Medicine.2023; 55(10): 912.     CrossRef
  • Emerging Systemic Therapies in Advanced Unresectable Biliary Tract Cancer: Review and Canadian Perspective
    Vincent C. Tam, Ravi Ramjeesingh, Ronald Burkes, Eric M. Yoshida, Sarah Doucette, Howard J. Lim
    Current Oncology.2022; 29(10): 7072.     CrossRef
  • 3,817 View
  • 223 Download
  • 9 Web of Science
  • 9 Crossref
Close layer
Systematic Review and Meta-Analysis
Confocal Laser Endomicroscopy in the Diagnosis of Biliary and Pancreatic Disorders: A Systematic Analysis
Do Han Kim, Somashekar G. Krishna, Emmanuel Coronel, Paul T. Kröner, Herbert C. Wolfsen, Michael B. Wallace, Juan E. Corral
Clin Endosc 2022;55(2):197-207.   Published online November 29, 2021
DOI: https://doi.org/10.5946/ce.2021.079
AbstractAbstract PDFPubReaderePub
Background
/Aims: Endoscopic visualization of the microscopic anatomy can facilitate the real-time diagnosis of pancreatobiliary disorders and provide guidance for treatment. This study aimed to review the technique, image classification, and diagnostic performance of confocal laser endomicroscopy (CLE).
Methods
We conducted a systematic review of CLE in pancreatic and biliary ducts of humans, and have provided a narrative of the technique, image classification, diagnostic performance, ongoing research, and limitations.
Results
Probe-based CLE differentiates malignant from benign biliary strictures (sensitivity, ≥89%; specificity, ≥61%). Needlebased CLE differentiates mucinous from non-mucinous pancreatic cysts (sensitivity, 59%; specificity, ≥94%) and identifies dysplasia. Pancreatitis may develop in 2-7% of pancreatic cyst cases. Needle-based CLE has potential applications in adenocarcinoma, neuroendocrine tumors, and pancreatitis (chronic or autoimmune). Costs, catheter lifespan, endoscopist training, and interobserver variability are challenges for routine utilization.
Conclusions
CLE reveals microscopic pancreatobiliary system anatomy with adequate specificity and sensitivity. Reducing costs and simplifying image interpretation will promote utilization by advanced endoscopists.

Citations

Citations to this article as recorded by  
  • Updates in Diagnosis and Endoscopic Management of Cholangiocarcinoma
    Roxana-Luiza Caragut, Madalina Ilie, Teodor Cabel, Deniz Günșahin, Afrodita Panaitescu, Christopher Pavel, Oana Mihaela Plotogea, Ecaterina Mihaela Rînja, Gabriel Constantinescu, Vasile Sandru
    Diagnostics.2024; 14(5): 490.     CrossRef
  • Endoscopic Ultrasound-Guided Needle-Based Confocal Endomicroscopy as a Diagnostic Imaging Biomarker for Intraductal Papillary Mucinous Neoplasms
    Shreyas Krishna, Ahmed Abdelbaki, Phil A. Hart, Jorge D. Machicado
    Cancers.2024; 16(6): 1238.     CrossRef
  • Exploring Intestinal Permeability: Concept, Diagnosis, Connection to Bowel Disease, and Iron Deficiency
    Olesja Basina, Aleksejs Derovs, Jeļena Derova, Sandra Lejniece
    Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences..2024; 78(4): 244.     CrossRef
  • American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the diagnosis of malignancy in biliary strictures of undetermined etiology: summary and recommendations
    Larissa L. Fujii-Lau, Nirav C. Thosani, Mohammad Al-Haddad, Jared Acoba, Curtis J. Wray, Rodrick Zvavanjanja, Stuart K. Amateau, James L. Buxbaum, Audrey H. Calderwood, Jean M. Chalhoub, Nayantara Coelho-Prabhu, Madhav Desai, Sherif E. Elhanafi, Douglas S
    Gastrointestinal Endoscopy.2023; 98(5): 685.     CrossRef
  • In Vivo Click Chemistry Enables Multiplexed Intravital Microscopy
    Jina Ko, Kilean Lucas, Rainer Kohler, Elias A. Halabi, Martin Wilkovitsch, Jonathan C. T. Carlson, Ralph Weissleder
    Advanced Science.2022;[Epub]     CrossRef
  • Endoscopic ultrasound-guided tissue acquisition: Needle types, technical issues, and sample handling
    Woo Hyun Paik
    International Journal of Gastrointestinal Intervention.2022; 11(3): 96.     CrossRef
  • 4,786 View
  • 237 Download
  • 5 Web of Science
  • 6 Crossref
Close layer
Original Article
Survival Benefit of Intraductal Radiofrequency Ablation for Malignant Biliary Obstruction: A Systematic Review with Meta-Analysis
Byung Hyo Cha, Myoung-Jin Jang, Sang Hyub Lee
Clin Endosc 2021;54(1):100-106.   Published online January 15, 2021
DOI: https://doi.org/10.5946/ce.2020.254
AbstractAbstract PDFPubReaderePub
Background
/Aims: Cholangiocarcinoma (CCA) is a rare but aggressive disease with a poor survival. Recent trials have shown improved survival with intraductal radiofrequency ablation (RFA) therapy. We performed a systematic review with meta-analysis to determine the survival benefit of endoscopic RFA for unresectable extrahepatic CCA with malignant biliary obstruction (MBO).
Methods
A systematic search from 1970 to 2020 was performed in MEDLINE, EMBASE, Cochrane Library, and ClinicalTrials. gov. We selected eligible studies reporting relative risks, hazard ratios (HRs), or odds ratios, adjusted by controlling for confounding factors of survival rate and stent patency duration, among patients with extrahepatic CCA with MBO treated with RFA with stent insertion or stent insertion only.
Results
A total of eight trials (three randomized and five nonrandomized) with a total of 420 patients were included in the metaanalysis. Pooled overall survival analysis favored RFA treatment with stent insertion (HR, 0.47; 95% confidence interval [CI], 0.34– 0.64; I2=47%; p=0.09); however, no significant difference was found in the duration of stent patency between the groups (HR, 0.79; 95% CI, 0.57–1.09; I2=7%; p=0.36).
Conclusions
RFA therapy with stent insertion may confer a survival benefit compared with stent insertion only in patients with CCA and MBO.

Citations

Citations to this article as recorded by  
  • Intraductal radiofrequency ablation plus biliary stent versus stent alone for malignant biliary obstruction: a systematic review and meta-analysis
    Matheus de Oliveira Veras, Diogo Turiani Hourneaux de Moura, Thomas R. McCarty, Guilherme Henrique Peixoto de Oliveira, Rômulo Sérgio Araújo Gomes, Davi Lucena Landim, Felipe Giacobo Nunes, Tomazo Antônio Prince Franzini, Marcos Eduardo Lera dos Santos, W
    Endoscopy International Open.2024; 12(01): E23.     CrossRef
  • Reply to Chandrasekhara and Aggarwal
    Matheus de Oliveira Veras, Diogo Turiani Hourneaux de Moura, Eduardo Guimarães Hourneaux de Moura
    Endoscopy International Open.2024; 12(05): E640.     CrossRef
  • Consensus statements on endoscopic radiofrequency ablation for malignant biliary strictures

    Journal of Digestive Diseases.2024; 25(1): 2.     CrossRef
  • The Impact of Radiofrequency Ablation on Survival Outcomes and Stent Patency in Patients with Unresectable Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Daniele Balducci, Michele Montori, Francesco Martini, Marco Valvano, Federico De Blasio, Maria Eva Argenziano, Giuseppe Tarantino, Antonio Benedetti, Emanuele Bendia, Marco Marzioni, Luca Maroni
    Cancers.2024; 16(7): 1372.     CrossRef
  • Impact of temperature-controlled endobiliary radiofrequency ablation for inoperable hilar cholangiocarcinoma: A propensity score–matched analysis
    Il Sang Shin, Jong Ho Moon, Yun Nah Lee, Jun Ho Myeong, Tae Hoon Lee, Jae Kook Yang, Young Deok Cho, Sang-Heum Park
    Endoscopy International Open.2024; 12(04): E535.     CrossRef
  • Percutaneous endobiliary radiofrequency ablation and stent placement for unresectable malignant biliary obstruction: a propensity score matching retrospective study
    Wei Cui, Jing-Zhi Huang, Qi Wang, Feng Shi, Qing Gou, Xiao-Ming Chen, Jing Zhang, Jia-Ping Li, Rongde Xu
    BMC Gastroenterology.2024;[Epub]     CrossRef
  • Biliary stents for active materials and surface modification: Recent advances and future perspectives
    Yuechuan Li, Kunshan Yuan, Chengchen Deng, Hui Tang, Jinxuan Wang, Xiaozhen Dai, Bing Zhang, Ziru Sun, Guiying Ren, Haijun Zhang, Guixue Wang
    Bioactive Materials.2024; 42: 587.     CrossRef
  • Chinese national clinical practice guideline on diagnosis and treatment of biliary tract cancers
    Xu’an Wang, Yongrui Bai, Ningli Chai, Yexiong Li, Enqiang Linghu, Liwei Wang, Yingbin Liu
    Chinese Medical Journal.2024;[Epub]     CrossRef
  • Feasibility and safety of trans-biliary cryoablation: Preclinical evaluation of a novel flexible cryoprobe
    Chao Zhang, Linzhong Zhu, Shousheng Tang, Jukun Wang, Yu Li, Xin Chen, Chunjing Bian, Dongbin Liu, Guokun Ao, Tao Luo
    Cryobiology.2023; 111: 40.     CrossRef
  • Efficacy and Safety of Radiofrequency Ablation Plus Stent Versus Stent-alone Treatments for Malignant Biliary Strictures
    Hayat Khizar, Yufei Hu, Yanhua Wu, Kamran Ali, Junaid Iqbal, Muhammad Zulqarnain, Jianfeng Yang
    Journal of Clinical Gastroenterology.2023; 57(4): 335.     CrossRef
  • Development of novel biliary metal stent with coil-spring structure and its application in vivo swine biliary stricture model
    In Rae Cho, Sang Hyub Lee, Jin Ho Choi, Namyoung Park, Min Woo Lee, Joo Seong Kim, Seok Jeong, Don Haeng Lee, Tae-Won Jeong, Byoung-Yun Ki, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • In-stent radiofrequency ablation with uncovered metal stent placement for tumor ingrowth/overgrowth causing self-expandable metal stent occlusion in distal malignant biliary obstruction: multicenter propensity score–matched study
    Namyoung Park, Min Kyu Jung, Eui Joo Kim, Woo Hyun Paik, Jae Hee Cho
    Gastrointestinal Endoscopy.2023; 97(4): 694.     CrossRef
  • ACG Clinical Guideline: Diagnosis and Management of Biliary Strictures
    B. Joseph Elmunzer, Jennifer L. Maranki, Victoria Gómez, Anna Tavakkoli, Bryan G. Sauer, Berkeley N. Limketkai, Emily A. Brennan, Elaine M. Attridge, Tara J. Brigham, Andrew Y. Wang
    American Journal of Gastroenterology.2023; 118(3): 405.     CrossRef
  • Effect of radiofrequency ablation in addition to biliary stent on overall survival and stent patency in malignant biliary obstruction: an updated systematic review and meta-analysis
    Zahid Ijaz Tarar, Umer Farooq, Mustafa Gandhi, Ghulam Ghous, Saad Saleem, Faisal Kamal, Zaid Imam, Laith Jamil
    European Journal of Gastroenterology & Hepatology.2023; 35(6): 646.     CrossRef
  • Impact of endobiliary radiofrequency ablation on survival of patients with unresectable cholangiocarcinoma: a narrative review
    Elena Di Girolamo, Andrea Belli, Alessandro Ottaiano, Vincenza Granata, Valentina Borzillo, Luca Tarotto, Fabiana Tatangelo, Raffaele Palaia, Corrado Civiletti, Mauro Piccirillo, Valentina D’Angelo, Francesco Fiore, Pietro Marone, Guglielmo Nasti, Frances
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial
    Jana Jarosova, Lea Zarivnijova, Ivana Cibulkova, Jan Mares, Peter Macinga, Alzbeta Hujova, Premysl Falt, Ondrej Urban, Jan Hajer, Julius Spicak, Tomas Hucl
    Gut.2023; 72(12): 2286.     CrossRef
  • Is endoscopic radiofrequency ablation plus stent placement superior to stent placement alone for the treatment of malignant biliary obstruction? A systematic review and meta-analysis
    Chenming Liu, Jiaming Dong, Yuxing Liu, Siyuan Zhang, Ruanchang Chen, Haijun Tang
    Journal of International Medical Research.2023;[Epub]     CrossRef
  • Intraductal Therapies for Cholangiocarcinoma
    Abhishek Agnihotri, David E. Loren
    Techniques and Innovations in Gastrointestinal Endoscopy.2022; 24(2): 200.     CrossRef
  • Silver Nanofunctionalized Stent after Radiofrequency Ablation Suppresses Tissue Hyperplasia and Bacterial Growth
    Yubeen Park, Dong-Sung Won, Ga-Hyun Bae, Dae Sung Ryu, Jeon Min Kang, Ji Won Kim, Song Hee Kim, Chu Hui Zeng, Wooram Park, Sang Soo Lee, Jung-Hoon Park
    Pharmaceutics.2022; 14(2): 412.     CrossRef
  • Comparison of Intraductal RFA Plus Stent versus Stent-Only Treatment for Unresectable Perihilar Cholangiocarcinoma—A Systematic Review and Meta-Analysis
    David M. de Jong, Jeska A. Fritzsche, Amber S. Audhoe, Suzanne S. L. Yi, Marco J. Bruno, Rogier P. Voermans, Lydi M. J. W. van Driel
    Cancers.2022; 14(9): 2079.     CrossRef
  • Evaluation and Management of Malignant Biliary Obstruction
    Nadia V. Guardado, Kaysey Llorente, Benoit Blondeau
    Surgical Oncology Clinics of North America.2021; 30(3): 491.     CrossRef
  • 4,574 View
  • 156 Download
  • 19 Web of Science
  • 21 Crossref
Close layer
Review
Role of Endoscopy in Primary Sclerosing Cholangitis
Purnima Bhat, Lars Aabakken
Clin Endosc 2021;54(2):193-201.   Published online May 8, 2020
DOI: https://doi.org/10.5946/ce.2020.019-IDEN
AbstractAbstract PDFPubReaderePub
Primary sclerosing cholangitis (PSC) is a progressive disease of the bile ducts that usually results in chronic liver disease often requiring liver transplantation. Endoscopy remains crucial to the care of these patients, although magnetic resonance cholangiopancreatography has replaced endoscopic retrograde cholangiopancreatography (ERCP) as the primary imaging modality for diagnosis. For detection of dysplasia or cholangiocarcinoma, ERCP with intraductal sampling remains compulsory. Moreover, dominant strictures play an important part in the disease development, and management by balloon dilatation or stenting could contribute to long-term prognosis. In addition, endoscopy offers management for adverse events such as bile leaks and anastomotic strictures after liver transplantation. Finally, the special phenotype of inflammatory bowel disease associated with PSC as well as the frequent occurrence of portal hypertension mandates close follow-up with colonoscopy and upper endoscopy. With the emergence of novel techniques, the endoscopist remains a key member of the multidisciplinary team caring for PSC patients.

Citations

Citations to this article as recorded by  
  • The additional value of the combined use of EUS and ERCP for the evaluation of unclear biliary strictures
    Eszter Bényei, Antonio Molinaro, Per Hedenström, Riadh Sadik
    Scandinavian Journal of Gastroenterology.2024; 59(8): 980.     CrossRef
  • Antibiotic prophylaxis and its effect on postprocedural adverse events in endoscopic retrograde cholangiopancreatography for primary sclerosing cholangitis
    Arvid Gustafsson, Lars Enochsson, Bobby Tingstedt, Greger Olsson
    JGH Open.2023; 7(1): 24.     CrossRef
  • Primary sclerosing cholangitis—A long night's journey into day
    Roger W. Chapman
    Clinical Liver Disease.2022; 20(S1): 21.     CrossRef
  • 11,361 View
  • 298 Download
  • 4 Web of Science
  • 3 Crossref
Close layer
Original Article
Inside Plastic Stents versus Metal Stents for Treating Unresectable Malignant Perihilar Biliary Obstructions: A Retrospective Comparative Study
Yoshihide Kanno, Shinsuke Koshita, Takahisa Ogawa, Hiroaki Kusunose, Kaori Masu, Toshitaka Sakai, Keisuke Yonamine, Kazuaki Miyamoto, Toji Murabayashi, Fumisato Kozakai, Jun Horaguchi, Yutaka Noda, Kei Ito
Clin Endosc 2020;53(6):735-742.   Published online March 4, 2020
DOI: https://doi.org/10.5946/ce.2020.003
AbstractAbstract PDFPubReaderePub
Background
/Aims: The aim of this study was to evaluate outcomes of inside plastic stents (iPSs) versus those of metal stents (MSs) for treating unresectable perihilar malignant obstructions.
Methods
For all patients who underwent endoscopic suprapapillary placement of iPS(s) or MS(s) as the first permanent biliary drainage for unresectable malignant perihilar obstructions between January 2014 and August 2019, clinical outcomes using iPSs (n=20) and MSs (n=85), including clinical efficacy, adverse events, and time to recurrence of biliary obstruction (RBO), were retrospectively evaluated.
Results
There were no differences in clinical effectiveness (95% for the iPS group vs. 92% for the MS group, p=1.00). Procedure-related adverse events, including pancreatitis, acute cholangitis, acute cholecystitis, and death, were observed for 8% of the MS group, although no patient in the iPS group developed such adverse events. The median time to RBO was 561 days (95% confidence interval, 0–1,186 days) for iPSs and 209 days (127–291 days) for MSs, showing a significant difference (p=0.008).
Conclusions
Time to RBO after iPS placement was significantly longer than that after MS placement. IPSs, which are removable, unlike MSs, were an acceptable option.

Citations

Citations to this article as recorded by  
  • Unilateral drainage and chemotherapy prolong the patency of a plastic stent placed above the sphincter of Oddi in patients with malignant hilar biliary obstruction
    Fumimasa Tomooka, Koh Kitagawa, Akira Mitoro, Yukihisa Fujinaga, Norihisa Nishimura, Tadashi Namisaki, Takemi Akahane, Kosuke Kaji, Shohei Asada, Shinya Sato, Jun‐Ichi Hanatani, Hitoshi Mori, Yuki Motokawa, Tomihiro Iwata, Hiroki Kachi, Yui Osaki, Hitoshi
    DEN Open.2025;[Epub]     CrossRef
  • Endoscopic nasobiliary drainage versus endoscopic biliary stenting for preoperative biliary drainage in patients with malignant hilar biliary obstruction: Propensity score‐matched multicenter comparative study
    Hirotoshi Ishiwatari, Takanori Kawabata, Hiroki Kawashima, Yousuke Nakai, Shin Miura, Hironari Kato, Hideyuki Shiomi, Nao Fujimori, Takeshi Ogura, Osamu Inatomi, Kensuke Kubota, Toshio Fujisawa, Mamoru Takenaka, Hiroshi Mori, Kensaku Noguchi, Yuki Fujii,
    Digestive Endoscopy.2024; 36(6): 726.     CrossRef
  • Comparison of unilateral and bilateral intraductal plastic stent placement for unresectable malignant hilar biliary obstruction: A propensity score‐matched cohort analysis
    Mitsuru Okuno, Keisuke Iwata, Tsuyoshi Mukai, Yuhei Iwasa, Shinya Uemura, Kensaku Yoshida, Akinori Maruta, Takuji Iwashita, Ichiro Yasuda, Masahito Shimizu
    Journal of Hepato-Biliary-Pancreatic Sciences.2024; 31(4): 284.     CrossRef
  • A Novel Method of Calculating the Drained Liver Volume Using a 3D Volume Analyzer for Biliary Drainage of Unresectable Malignant Hilar Biliary Obstruction
    Naoto Imagawa, Mitsuharu Fukasawa, Shinichi Takano, Satoshi Kawakami, Yoshimitsu Fukasawa, Hiroyuki Hasegawa, Natsuhiko Kuratomi, Shota Harai, Naruki Shimamura, Dai Yoshimura, Shoji Kobayashi, Takashi Yoshida, Mitsuaki Sato, Yuichiro Suzuki, Nobuyuki Enom
    Digestive Diseases and Sciences.2024; 69(3): 969.     CrossRef
  • Partial Stent-in-Stent Method with an Uncovered Self-Expandable Metallic Stent for Unresectable Malignant Hilar Bile Duct Obstruction
    Takuya Shimosaka, Yohei Takeda, Taro Yamashita, Yuta Seki, Shiho Kawahara, Takayuki Hirai, Noriyuki Suto, Yuri Sakamoto, Wataru Hamamoto, Hiroki Koda, Takumi Onoyama, Kazuya Matsumoto, Kazuo Yashima, Hajime Isomoto, Naoyuki Yamaguchi
    Journal of Clinical Medicine.2024; 13(3): 820.     CrossRef
  • Current status of preoperative endoscopic biliary drainage for distal and hilar biliary obstruction
    Hirotoshi Ishiwatari, Junya Sato, Hiroki Sakamoto, Takuya Doi, Hiroyuki Ono
    Digestive Endoscopy.2024;[Epub]     CrossRef
  • Biliary drainage in hilar and perihilar cholangiocarcinoma: 25-year experience at a tertiary cancer center
    Ahmad Al Nakshabandi, Faisal S. Ali, Iyad Albustami, Hyunsoo Hwang, Wei Qiao, Nicole C. Johnston, Abdullah S. Shaikh, Emmanuel Coronel, Phillip S. Ge, William Ross, Brian Weston, Jeffrey H. Lee
    Gastrointestinal Endoscopy.2024; 99(6): 938.     CrossRef
  • Safety and efficacy of biliary suprapapillary metal and plastic stents in malignant biliary obstruction: a systematic review and meta-analysis
    Saqr Alsakarneh, Mahmoud Y. Madi, Fouad Jaber, Kamal Hassan, Yassine Kilani, Omar Al Ta’ani, Dushyant Singh Dahiya, Amir H. Sohail, Laith Numan, Mohammad Bilal, Wissam Kiwan
    Surgical Endoscopy.2024; 38(8): 4186.     CrossRef
  • Clinical Outcomes of Inside Stents and Conventional Plastic Stents as Bridge-to-Surgery Options for Malignant Hilar Biliary Obstruction
    Hirotoshi Ishiwatari, Takanori Kawabata, Hiroki Kawashima, Yousuke Nakai, Shin Miura, Hironari Kato, Hideyuki Shiomi, Nao Fujimori, Takeshi Ogura, Osamu Inatomi, Kensuke Kubota, Toshio Fujisawa, Mamoru Takenaka, Hiroshi Mori, Kensaku Noguchi, Yuki Fujii,
    Digestive Diseases and Sciences.2023; 68(4): 1139.     CrossRef
  • Development of novel biliary metal stent with coil-spring structure and its application in vivo swine biliary stricture model
    In Rae Cho, Sang Hyub Lee, Jin Ho Choi, Namyoung Park, Min Woo Lee, Joo Seong Kim, Seok Jeong, Don Haeng Lee, Tae-Won Jeong, Byoung-Yun Ki, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Endoscopic retrograde stent drainage therapies for malignant biliary obstruction: the distal opening of stent location above or across the duodenal papilla? A systematic review and meta-analysis
    Dong Fang, Yi Han, Chenglin Zhu, Zhenwang Shi, Deming Bao, Liming Wang, Qin Xu
    Scandinavian Journal of Gastroenterology.2023; 58(9): 1071.     CrossRef
  • Suprapapillary placement of plastic versus metal stents for malignant biliary hilar obstructions: a multicenter, randomized trial
    Yoshihide Kanno, Kei Ito, Kazunari Nakahara, Shinya Kawaguchi, Yoshiharu Masaki, Toru Okuzono, Hironari Kato, Masaki Kuwatani, Shotaro Ishii, Toji Murabayashi, Sho Hasegawa, Masatsugu Nagahama, Yuji Iwashita, Yosuke Michikawa, Shuzo Terada, Yujiro Kawakam
    Gastrointestinal Endoscopy.2023; 98(2): 211.     CrossRef
  • Déjà vu but with a different conclusion
    Richard Kozarek
    Gastrointestinal Endoscopy.2023; 98(5): 787.     CrossRef
  • Utility of bilateral intraductal plastic stent for malignant hilar biliary obstruction compared with bilateral self-expandable metal stent: a propensity score–matched cohort analysis
    Mitsuru Okuno, Keisuke Iwata, Takuji Iwashita, Tsuyoshi Mukai, Kota Shimojo, Yosuke Ohashi, Yuhei Iwasa, Akihiko Senju, Shota Iwata, Ryuichi Tezuka, Hironao Ichikawa, Naoki Mita, Shinya Uemura, Kensaku Yoshida, Akinori Maruta, Eiichi Tomita, Ichiro Yasuda
    Gastrointestinal Endoscopy.2023; 98(5): 776.     CrossRef
  • Cross‐wired metal stents for endoscopic bilateral stent‐in‐stent deployment in malignant hilar biliary obstruction: A multicenter, single‐arm, prospective study
    Kentaro Yamao, Takeshi Ogura, Hideyuki Shiomi, Takaaki Eguchi, Hisakazu Matsumoto, Zhao Liang Li, Hiroaki Hashimoto, Yasutaka Chiba, Mamoru Takenaka, Tomohiro Watanabe, Masatoshi Kudo, Tsuyoshi Sanuki
    DEN Open.2022;[Epub]     CrossRef
  • Recent advances regarding endoscopic biliary drainage for unresectable malignant hilar biliary obstruction
    Hironari Kato, Kazuyuki Matsumoto, Hiroyuki Okada
    DEN Open.2022;[Epub]     CrossRef
  • Double‐scope method is helpful to rescue a retrieval thread attached to a stent caught on the duodenoscope forceps elevator
    Kengo Matsumoto, Dai Nakamatsu, Tsutomu Nishida
    Digestive Endoscopy.2022;[Epub]     CrossRef
  • The feasibility of percutaneous transhepatic gallbladder aspiration for acute cholecystitis after self-expandable metallic stent placement for malignant biliary obstruction: a 10-year retrospective analysis in a single center
    Akihisa Ohno, Nao Fujimori, Toyoma Kaku, Masayuki Hijioka, Ken Kawabe, Naohiko Harada, Makoto Nakamuta, Takamasa Oono, Yoshihiro Ogawa
    Clinical Endoscopy.2022; 55(6): 784.     CrossRef
  • Self‐expandable metal stents have longer patency and less cholangitis than inside stents in malignant perihilar biliary obstruction
    Akinobu Koiwai, Morihisa Hirota, Tomofumi Katayama, Ryo Kin, Keita Kawamura, Katsuya Endo, Takayuki Kogure, Atsuko Takasu, Takayoshi Meguro, Kennichi Satoh
    JGH Open.2022; 6(5): 317.     CrossRef
  • Two-devices-in-one-channel method for preventing the preceding stent migration in case of multiple indwelling biliary inside plastic stents
    Tesshin Ban, Yoshimasa Kubota, Takuya Takahama, Shun Sasoh, Tomoaki Ando, Makoto Nakamura, Takashi Joh
    Endoscopy.2022; 54(S 02): E948.     CrossRef
  • Editors' Choice of Noteworthy Clinical Endoscopy Publications in the First Decade
    Gwang Ha Kim, Kwang An Kwon, Do Hyun Park, Jimin Han
    Clinical Endoscopy.2021; 54(5): 633.     CrossRef
  • Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how?
    Tudor Mocan, Adelina Horhat, Emil Mois, Florin Graur, Cristian Tefas, Rares Craciun, Iuliana Nenu, Mihaela Spârchez, Zeno Sparchez
    World Journal of Gastrointestinal Oncology.2021; 13(12): 2050.     CrossRef
  • Changing Trends in Biliary Stenting for Unresectable Malignant Perihilar Obstructions
    Lubna Kamani, Muhammad Arshad
    Clinical Endoscopy.2020; 53(6): 636.     CrossRef
  • 5,754 View
  • 247 Download
  • 23 Web of Science
  • 23 Crossref
Close layer
Review
The Role of Peroral Cholangioscopy in Evaluating Indeterminate Biliary Strictures
Nasim Parsa, Mouen A. Khashab
Clin Endosc 2019;52(6):556-564.   Published online July 16, 2019
DOI: https://doi.org/10.5946/ce.2019.011
AbstractAbstract PDFPubReaderePub
Biliary strictures are considered indeterminate when the initial radiologic evaluation and endoscopic retrograde cholangiopancreatography with brush cytology and/or forceps biopsy do not reveal diagnostic findings. Evaluation of these strictures is challenging and often requires a multidisciplinary approach and multiple procedures. Peroral cholangioscopy allows direct visualization of these lesions and targeted tissue acquisition using miniature biopsy forceps. In the past decade, there have been significant improvements in the field of cholangioscopy. These advances have allowed higher-quality image acquisition, easy setup, operation by a single operator, easy maneuverability, and excellent targeted tissue sampling performance. However, the interpretation of cholangioscopic visual findings remains challenging. In this review, we discuss the role of peroral cholangioscopy in the evaluation of indeterminate biliary strictures.

Citations

Citations to this article as recorded by  
  • Endoscopic Diagnosis of Extra-Luminal Cancers
    Ross C.D. Buerlein, Vanessa M. Shami
    Gastrointestinal Endoscopy Clinics of North America.2024; 34(1): 19.     CrossRef
  • Endoscopic Management of Difficult Biliary Stones: An Evergreen Issue
    Magdalini Manti, Jimil Shah, Apostolis Papaefthymiou, Antonio Facciorusso, Daryl Ramai, Georgios Tziatzios, Vasilios Papadopoulos, Konstantina Paraskeva, Ioannis S. Papanikolaou, Konstantinos Triantafyllou, Marianna Arvanitakis, Livia Archibugi, Giuseppe
    Medicina.2024; 60(2): 340.     CrossRef
  • Use of catheter-based cholangioscopy in the diagnosis of indeterminate stenosis: a multicenter experience
    Socrate PALLIO, Emanuele SINAGRA, Alessio SANTAGATI, Fabio D’AMORE, Giancarlo POMPEI, Giuseppe CONOSCENTI, Fabio ROMEO, Eleonora BORINA, Giuseppinella MELITA, Francesca ROSSI, Marcello MAIDA, Rita ALLORO, Ilaria TARANTINO, Dario RAIMONDO
    Minerva Gastroenterology.2024;[Epub]     CrossRef
  • Accurate and safe diagnosis and treatment of neoplastic biliary lesions using a novel 9F and 11F digital single-operator cholangioscope
    Carlos Robles-Medranda, Juan Alcivar-Vasquez, Isaac Raijman, Michel Kahaleh, Miguel Puga-Tejada, Raquel Del Valle, Haydee Alvarado, Carlos Cifuentes-Gordillo, Kenneth F. Binmoeller, Alberto Jose Baptista, Jonathan Barreto-Perez, Jorge Rodriguez, Maria Ega
    Endoscopy International Open.2024; 12(04): E498.     CrossRef
  • Disposable Gastrointestinal Scopes: A Systematic Review
    Matthew Udine, Mallorie L. Huff, Katherine Tsay, Abdul-Rahman F. Diab, Joseph Sujka, Christopher DuCoin, Salvatore Docimo
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2024; 34(3): 321.     CrossRef
  • Direct Single-Operator Cholangioscopy and Intraductal Ultrasonography in Patients with Indeterminate Biliary Strictures: A Single Center Experience
    Marco Sacco, Marcantonio Gesualdo, Maria Teresa Staiano, Eleonora Dall’Amico, Stefania Caronna, Simone Dibitetto, Chiara Canalis, Alessandro Caneglias, Federica Mediati, Rosa Claudia Stasio, Silvia Gaia, Giorgio Maria Saracco, Mauro Bruno, Claudio Giovann
    Diagnostics.2024; 14(13): 1316.     CrossRef
  • A novel peroral digital cholangioscope with a large accessory channel: An experimental study
    Ryosuke Tonozuka, Takao Itoi, Kazumasa Nagai, Atsushi Sofuni, Takayoshi Tsuchiya, Kentaro Ishii, Reina Tanaka, Shuntaro Mukai, Hirohito Minami, Kenjiro Yamamoto
    Journal of Hepato-Biliary-Pancreatic Sciences.2023; 30(3): 401.     CrossRef
  • Peroral Cholangioscopy in the Diagnosis and Treatment of Biliary Strictures
    M. I. Bykov, A. Y. Mnatsakanian, A. A. Taran
    Innovative Medicine of Kuban.2023; (1): 79.     CrossRef
  • Qualitative Diagnosis of Biliary Stricture
    正军 孔
    Advances in Clinical Medicine.2023; 13(09): 14098.     CrossRef
  • Digital Cholangioscopic Interpretation: When North Meets the South
    Michel Kahaleh, Isaac Raijman, Monica Gaidhane, Amy Tyberg, Amrita Sethi, Adam Slivka, Douglas G. Adler, Divyesh Sejpal, Haroon Shahid, Avik Sarkar, Fernanda Martins, Christine Boumitri, Samuel Burton, Helga Bertani, Paul Tarnasky, Frank Gress, Ian Gan, J
    Digestive Diseases and Sciences.2022; 67(4): 1345.     CrossRef
  • Diagnostic performance of digital and video cholangioscopes in patients with suspected malignant biliary strictures: a systematic review and meta-analysis
    Santi Kulpatcharapong, Rapat Pittayanon, Stephen J Kerr, Rungsun Rerknimitr
    Surgical Endoscopy.2022; 36(5): 2827.     CrossRef
  • Next‐generation sequencing in the evaluation of biliary strictures in patients with primary sclerosing cholangitis
    Johannes F. Scheid, Matthew W. Rosenbaum, Eric M. Przybyszewski, Kumar Krishnan, David G. Forcione, Anthony J. Iafrate, Kyle D. Staller, Joseph Misdraji, Jochen K. Lennerz, Martha Bishop Pitman, Daniel S. Pratt
    Cancer Cytopathology.2022; 130(3): 215.     CrossRef
  • Improving Diagnostic Yield in Indeterminate Biliary Strictures
    David J. Restrepo, Chris Moreau, Cyrus V. Edelson, Ameesh Dev, Shreyas Saligram, Hari Sayana, Sandeep N. Patel
    Clinics in Liver Disease.2022; 26(1): 69.     CrossRef
  • Advanced Imaging Within the Bile Duct During Endoscopic Retrograde Cholangiopancreatography
    Kaveh Sharzehi, Gregory A. Cote
    Clinical Gastroenterology and Hepatology.2022; 20(4): 737.     CrossRef
  • Endoscopic Diagnosis of Cholangiocarcinoma
    Mohannad Abou Saleh, Prabhleen Chahal
    Techniques and Innovations in Gastrointestinal Endoscopy.2022; 24(2): 176.     CrossRef
  • A case of successful removal of a migrated fish bone in the bile duct after pancreaticoduodenectomy using overtube-assisted cholangioscopy
    Yuya Suzuki, Tetsuya Ishizawa, Naohiko Makino, Akiko Matsuda, Yasuharu Kakizaki, Toshikazu Kobayashi, Koki Ashino, Fuyuhiko Motoi, Yoshiyuki Ueno
    Clinical Journal of Gastroenterology.2022; 15(2): 493.     CrossRef
  • IgG4-related sclerosing cholangitis involving the gallbladder mimicking a hilar cholangiocarcinoma
    Yun Chae Lee, Hyung Ku Chon, Keum Ha Choi
    Endoscopy.2022; 54(12): E739.     CrossRef
  • Efficacy and safety of direct peroral cholangioscopy using a new multibending ultra‐slim endoscope for the management of biliary diseases
    Yun Nah Lee, Jong Ho Moon, Tae Hoon Lee, Hae Won Yoo, Jae Kook Yang, Sang‐Woo Cha, Young Deok Cho, Sang‐Heum Park
    Journal of Hepato-Biliary-Pancreatic Sciences.2022; 29(12): 1292.     CrossRef
  • Artificial intelligence in biliopancreatic endoscopy: Is there any role?
    Omer F. Ahmad, Pauline Stassen, George J. Webster
    Best Practice & Research Clinical Gastroenterology.2021; 52-53: 101724.     CrossRef
  • Artificial intelligence in pancreaticobiliary endoscopy
    Venkata S Akshintala, Mouen A Khashab
    Journal of Gastroenterology and Hepatology.2021; 36(1): 25.     CrossRef
  • Einfluss der Molekularpathologie auf die onkologische Chirurgie von Leber- und Gallengangstumoren
    Mazen A. Juratli, Benjamin Struecker, Shadi Katou, M. Haluk Morguel, Andreas Pascher
    Der Chirurg.2021; 92(11): 1003.     CrossRef
  • Diagnostic accuracy and interobserver agreement of digital single-operator cholangioscopy for indeterminate biliary strictures
    Pauline M.C. Stassen, George Goodchild, Pieter Jan F. de Jonge, Nicole S. Erler, Andrea Anderloni, Vincenzo Cennamo, Nicholas I. Church, Ignacio Fernandez-Urien Sainz, Matthew T. Huggett, Martin W. James, Deepak Joshi, Leena Kylänpää, Wim Laleman, Manu K.
    Gastrointestinal Endoscopy.2021; 94(6): 1059.     CrossRef
  • Biliary Strictures and Cholangiocarcinoma – Untangling a Diagnostic Conundrum
    Alexander Ney, Andres Garcia-Sampedro, George Goodchild, Pilar Acedo, Giuseppe Fusai, Stephen P. Pereira
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Editors' Choice of Noteworthy Clinical Endoscopy Publications in the First Decade
    Gwang Ha Kim, Kwang An Kwon, Do Hyun Park, Jimin Han
    Clinical Endoscopy.2021; 54(5): 633.     CrossRef
  • Diagnostic Approach to Suspected Perihilar Malignancy
    Evgeny Solonitsyn, Alexander Dechêne
    Visceral Medicine.2021; 37(1): 3.     CrossRef
  • Comparison of EUS and ERCP-guided tissue sampling in suspected biliary stricture
    Hye Gyo Chung, Jong-In Chang, Kwang Hyuk Lee, Joo Kyung Park, Kyu Taek Lee, Jong Kyun Lee, Zhen Hua Hu
    PLOS ONE.2021; 16(10): e0258887.     CrossRef
  • Choledochoscopy: An update
    Tsinrong Lee, Thomas Zheng Jie Teng, Vishal G Shelat
    World Journal of Gastrointestinal Endoscopy.2021; 13(12): 571.     CrossRef
  • Digital single-operator cholangioscopy for indeterminate biliary stricture: Enthusiasm or still evolving for unmet need?
    Hoonsub So, Do Hyun Park
    Gastrointestinal Endoscopy.2020; 91(2): 394.     CrossRef
  • Cholangiokarzinome – aktuelle Therapiestandards
    B. Struecker, H. Morguel, A. Pascher
    Der Onkologe.2020; 26(3): 238.     CrossRef
  • Efficacy of digital single-operator cholangioscopy in the visual interpretation of indeterminate biliary strictures: a systematic review and meta-analysis
    Pedro Victor Aniz Gomes de Oliveira, Diogo Turiani Hourneaux de Moura, Igor Braga Ribeiro, Ahmad Najdat Bazarbashi, Tomazo Antonio Prince Franzini, Marcos Eduardo Lera dos Santos, Wanderley Marques Bernardo, Eduardo Guimarães Hourneaux de Moura
    Surgical Endoscopy.2020; 34(8): 3321.     CrossRef
  • Role of Peroral Cholangioscopy in the Diagnosis of Primary Sclerosing Cholangitis
    Toshio Fujisawa, Mako Ushio, Sho Takahashi, Wataru Yamagata, Yusuke Takasaki, Akinori Suzuki, Yoshihiro Okawa, Kazushige Ochiai, Ko Tomishima, Shigeto Ishii, Hiroaki Saito, Hiroyuki Isayama
    Diagnostics.2020; 10(5): 268.     CrossRef
  • Digital image analysis has an additive beneficial role to conventional cytology in diagnosing the nature of biliary ducts stricture
    Ahmed Helmy, Heba Mohamed Saad Eldien, Adnan Ahmed Mohammed, Gehan Sayed Seifeldein, Ahmed Mohammed Abu-Elfatth
    Journal of Clinical and Experimental Hepatology.2020;[Epub]     CrossRef
  • Application of a single‐sleeved biopsy forceps in malignant biliopancreatic duct stricture
    Ping‐Ping Zhang, Pei‐Qin Wang, Dong Wang
    Digestive Endoscopy.2020; 32(6): 989.     CrossRef
  • Endoscopic Management of Pancreaticobiliary Disease
    Catherine F. Vozzo, Madhusudhan R. Sanaka
    Surgical Clinics of North America.2020; 100(6): 1151.     CrossRef
  • Determining the Indeterminate Biliary Stricture: Cholangioscopy and Beyond
    Nichol S. Martinez, Arvind J. Trindade, Divyesh V. Sejpal
    Current Gastroenterology Reports.2020;[Epub]     CrossRef
  • 7,461 View
  • 355 Download
  • 32 Web of Science
  • 35 Crossref
Close layer
Focused Review Series: Updates on Gastrointestinal and Pancreaticobiliary Stents
Update on Pancreatobiliary Stents: Stent Placement in Advanced Hilar Tumors
Sung Ill Jang, Dong Ki Lee
Clin Endosc 2015;48(3):201-208.   Published online May 29, 2015
DOI: https://doi.org/10.5946/ce.2015.48.3.201
AbstractAbstract PDFPubReaderePub

Palliative drainage is the main treatment option for inoperable hilar cholangiocarcinoma to improve symptoms, which include cholangitis, pruritus, high-grade jaundice, and abdominal pain. Although there is no consensus on the optimal method for biliary drainage due to the paucity of large-scale randomized control studies, several important aspects of any optimal method have been studied. In this review article, we discuss the liver volume to be drained, stent type, techniques to insert self-expanding metal stents, and approaches for proper and effective biliary drainage based on previous studies and personal experience.

Citations

Citations to this article as recorded by  
  • 3D-printed versatile biliary stents with nanoengineered surface for anti-hyperplasia and antibiofilm formation
    Hyun Lee, Dong-Sung Won, Sinwoo Park, Yubeen Park, Ji Won Kim, Ginam Han, Yuhyun Na, Min-Ho Kang, Seok Beom Kim, Heemin Kang, Jun-Kyu Park, Tae-Sik Jang, Sang Jin Lee, Su A. Park, Sang Soo Lee, Jung-Hoon Park, Hyun-Do Jung
    Bioactive Materials.2024; 37: 172.     CrossRef
  • Endoscopic Retrograde Cholangiopancreatography Stenting for Hilar Cholangiocarcinoma
    Mohammad Bilal, Martin L. Freeman
    Techniques and Innovations in Gastrointestinal Endoscopy.2022; 24(2): 190.     CrossRef
  • Stent with radioactive seeds strand insertion for malignant hilar biliary obstruction
    Gang Chen, Mei Zhang, Yu-Guo Sheng, Fang Yang, Zhong-Qi Li, Tong-Gang Liu, Yu-Fei Fu
    Minimally Invasive Therapy & Allied Technologies.2021; 30(6): 356.     CrossRef
  • Unilateral Versus Side-By-Side Metal Stenting for Malignant Hilar Biliary Obstruction: A Meta-Analysis
    Zhong-Ke Chen, Wei Zhang, Yuan-Shun Xu, Yu Li
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2021; 31(2): 203.     CrossRef
  • A preliminary single-center investigation of percutaneous biliary stenting in malignant hilar biliary obstruction: what impacts the clinical success and the long-term outcomes?
    Xiaonan Mao, Feng Wen, Hongyuan Liang, Wei Sun, Zaiming Lu
    Supportive Care in Cancer.2021; 29(11): 6781.     CrossRef
  • Unilateral Stent Insertion With High-intensity Focused Ultrasound Ablation for Hilar Cholangiocarcinoma
    Qiang Cao, Juan-Juan Li, Tao Feng, Yi-Bing Shi, Gang Wang, Feng-Fei Xia
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2020; 30(3): 281.     CrossRef
  • Comparison of Unilateral With Bilateral Metal Stenting for Malignant Hilar Biliary Obstruction
    Fei Teng, Yu-Tao Xian, Jia Lin, Yu Li, An-Le Wu
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2019; 29(1): 43.     CrossRef
  • Percutaneous stenting for malignant hilar biliary obstruction: a randomized controlled trial of unilateral versus bilateral stenting
    Yu-Fei Fu, Wen-Jie Zhou, Yi-Bing Shi, Wei Cao, Chi Cao
    Abdominal Radiology.2019; 44(8): 2900.     CrossRef
  • Self-Expanded Metallic Stent Insertion for Hilar Cholangiocarcinoma: Comparison of Unilateral and Bilateral Stenting
    Xue Yin, Dong-Mei Li, Fang Yang, Tong-Gang Liu, Feng-Fei Xia, Yu-Fei Fu
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2019; 29(12): 1501.     CrossRef
  • Percutaneous stent placement for malignant hilar biliary obstruction: a comparison between criss-cross and T-configuration techniques
    C.H. Jeon, C.J. Yoon, N.J. Seong, H. Lee, J.H. Hwang, J. Kim
    Clinical Radiology.2018; 73(4): 412.e9.     CrossRef
  • Placement of a Newly Designed Y-Configured Bilateral Self-Expanding Metallic Stent for Hilar Biliary Obstruction: A Pilot Study
    Dechao Jiao, Kai Huang, Ming Zhu, Gang Wu, Jianzhuang Ren, Yanli Wang, Xinwei Han
    Digestive Diseases and Sciences.2017; 62(1): 253.     CrossRef
  • Unilateral versus bilateral stent insertion for malignant hilar biliary obstruction
    Gang Chang, Feng-Fei Xia, Hong-Fu Li, Su Niu, Yuan-Shun Xu
    Abdominal Radiology.2017; 42(11): 2745.     CrossRef
  • Optimizing palliation of malignant hilar strictures by the use of endobiliary stents
    Jeffery J. Easler, Stuart Sherman, Gregory A. Coté
    Gastrointestinal Endoscopy.2017; 86(5): 828.     CrossRef
  • Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma
    Jian Lu, Jin-He Guo, Hai-Dong Zhu, Guang-Yu Zhu, Yong Wang, Qi Zhang, Li Chen, Chao Wang, Tian-Fan Pan, Gao-Jun Teng
    ESMO Open.2017; 2(4): e000242.     CrossRef
  • Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study
    Yaoting Chen, Huiqing Li, Xiongying Jiang, Dong Chen, Jiayan Ni, Hongliang Sun, Jianghong Luo, Herui Yao, Linfeng Xu
    European Radiology.2016; 26(10): 3500.     CrossRef
  • Current Status of Biliary Metal Stents
    Hyeong Seok Nam, Dae Hwan Kang
    Clinical Endoscopy.2016; 49(2): 124.     CrossRef
  • 9,719 View
  • 143 Download
  • 19 Web of Science
  • 16 Crossref
Close layer
Focused Review Series: Advanced Endoscopic Treatment for Pancreaticobiliary Diseases
Endoscopic Ablation Therapy for Biliopancreatic Malignancies
Jason Roque, Shiaw-Hooi Ho, Nageshwar Reddy, Khean-Lee Goh
Clin Endosc 2015;48(1):15-19.   Published online January 31, 2015
DOI: https://doi.org/10.5946/ce.2015.48.1.15
AbstractAbstract PDFPubReaderePub

Biliopancreatic malignancies such as cholangiocarcinoma (CCA) has notoriously been diagnosed late. As such most therapy have been palliative in nature. Cholangioscopy allows for an earlier diagnosis to be made. Brachytherapy with the insertion of catheter with iridium-132 seeds, percutaneously or through endoscopic retrograde cholangiopancreatography (ERCP) was the earliest ablative techniques used. It has been shown to have a beneficial effect only in prolonging survival. Photodynamic therapy (PDT) has also been used for several years. stenting with PDT versus stenting alone for unresectable CCA showed a marked survival benefit with the addition of PDT. However the most exciting endoscopic ablative modality appears to be intraductal radiofrequency ablation using the Habib catheter and device. Several case series have shown the effectiveness of this technique in ablating tumors. This technique is evolving and coupled with early diagnosis of CCA through cholangioscopy will allow for a curative therapy. The crux to the effective treatment of early cancerous lesions in the bile or pancreatic duct is the early diagnosis of such lesions. Effective endoscopic ablative therapy is now available with the advent of radiofrequency ablation probes that can be passed through the duodenoscope via ERCP.

Citations

Citations to this article as recorded by  
  • Clinical and cost effectiveness of endoscopic bipolar radiofrequency ablation for the treatment of malignant biliary obstruction: a systematic review
    Fiona Beyer, Stephen Rice, Giovany Orozco-Leal, Madeleine Still, Hannah O’Keefe, Nicole O’Connor, Akvile Stoniute, Dawn Craig, Stephen Pereira, Louise Carr, John Leeds
    Health Technology Assessment.2023; : 1.     CrossRef
  • Impact of endobiliary radiofrequency ablation on survival of patients with unresectable cholangiocarcinoma: a narrative review
    Elena Di Girolamo, Andrea Belli, Alessandro Ottaiano, Vincenza Granata, Valentina Borzillo, Luca Tarotto, Fabiana Tatangelo, Raffaele Palaia, Corrado Civiletti, Mauro Piccirillo, Valentina D’Angelo, Francesco Fiore, Pietro Marone, Guglielmo Nasti, Frances
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Endoscopic Management of Pancreatobiliary Malignancies
    Dong Wook Lee, Eun Young Kim
    Digestive Diseases and Sciences.2022; 67(5): 1635.     CrossRef
  • Survival Benefit of Intraductal Radiofrequency Ablation for Malignant Biliary Obstruction: A Systematic Review with MetaAnalysis
    Byung Hyo Cha, Myoung-Jin Jang, Sang Hyub Lee
    Clinical Endoscopy.2021; 54(1): 100.     CrossRef
  • Biliary endoscopy in the management of primary sclerosing cholangitis and its complications
    Brian M. Fung, James H. Tabibian
    Liver Research.2019; 3(2): 106.     CrossRef
  • Diagnostic and therapeutic single-operator cholangiopancreatoscopy with SpyGlassDS™: results of a multicenter retrospective cohort study
    Felicia Turowski, Ulrich Hügle, Arno Dormann, Matthias Bechtler, Ralf Jakobs, Uwe Gottschalk, Ellen Nötzel, Dirk Hartmann, Albrecht Lorenz, Frank Kolligs, Wilfried Veltzke-Schlieker, Andreas Adler, Olaf Becker, Bertram Wiedenmann, Nataly Bürgel, Hanno Trö
    Surgical Endoscopy.2018; 32(9): 3981.     CrossRef
  • Klinischer Stellenwert der modularen Cholangioskopie
    C. Bojarski, F. Turowski
    Der Gastroenterologe.2017; 12(3): 202.     CrossRef
  • Radiofrequency ablation for management of malignant biliary obstruction: a single-center experience and review of the literature
    Amit Kumar Dutta, Umesh Basavaraju, Laura Sales, John Samuel Leeds
    Expert Review of Gastroenterology & Hepatology.2017; 11(8): 779.     CrossRef
  • Endoluminal Nd:YAG laser application in ex vivo biliary porcine tissue
    Roberta Rea, Francesco Maria Di Matteo, Margareth Martino, Monica Pandolfi, Paola Saccomandi, Carla Rabitti, Anna Crescenzi, Guido Costamagna
    Lasers in Medical Science.2017; 32(6): 1411.     CrossRef
  • Endoscopic management of hilar stricture
    Abhishek Gulati, Payal Thakkar, Shyam Thakkar
    Techniques in Gastrointestinal Endoscopy.2016; 18(2): 67.     CrossRef
  • Advances in Therapeutic Cholangioscopy
    Tomazo Antonio Prince Franzini, Renata Nobre Moura, Eduardo Guimarães Hourneaux de Moura
    Gastroenterology Research and Practice.2016; 2016: 1.     CrossRef
  • Review of endoscopic radiofrequency in biliopancreatic tumours with emphasis on clinical benefits, controversies and safety
    María-Victoria Alvarez-Sánchez, Bertrand Napoléon
    World Journal of Gastroenterology.2016; 22(37): 8257.     CrossRef
  • Aktuelle Therapiekonzepte für lokale Cholangiokarzinome
    D. Seehofer, T.B. Brunner, H. Wege
    Der Onkologe.2015; 21(11): 1054.     CrossRef
  • 7,563 View
  • 93 Download
  • 15 Web of Science
  • 13 Crossref
Close layer
Review
Bilateral Metallic Stenting in Malignant Hilar Obstruction
Tae Hoon Lee, Jong Ho Moon, Sang-Heum Park
Clin Endosc 2014;47(5):440-446.   Published online September 30, 2014
DOI: https://doi.org/10.5946/ce.2014.47.5.440
AbstractAbstract PDFPubReaderePub

Endoscopic palliative biliary drainage is considered as a gold standard treatment in advanced or inoperable hilar cholangiocarcinoma. Also, metal stents are preferred over plastic stents in patients with >3 months life expectancy. However, the endoscopic intervention of advanced hilar obstruction is often more challenging and complex than that of distal malignant biliary obstructions. In this literature review, we describe the issues commonly encountered during endoscopic unilateral (single) versus bilateral (multiple) biliary stenting for malignant hilar obstruction. Also, we provide technical guidance to improve the technical success rates and patient outcomes, focusing on bilateral metallic stenting techniques such as stent-in-stent or side-by-side deployment.

Citations

Citations to this article as recorded by  
  • Side‐by‐side placement of fully covered metal stents versus conventional 7F plastic stents in malignant hilar biliary obstruction: Prospective randomized controlled trial
    Woo Hyun Paik, Min Kyu Jung, Dong Uk Kim, Tae Jun Song, Min Jae Yang, Young Hoon Choi, Joo Seong Kim, Min Woo Lee, Jin Ho Choi, Sang Hyub Lee
    Digestive Endoscopy.2024; 36(4): 473.     CrossRef
  • Suprapapillary stenting for malignant hilar obstruction: Is it feasible in the West?
    Netanel F. Zilberstein, Neal A. Mehta
    Gastrointestinal Endoscopy.2023; 98(2): 222.     CrossRef
  • Endoscopic re‐intervention after stent‐in‐stent versus side‐by‐side bilateral self‐expandable metallic stent deployment
    Tomohisa Iwai, Mitsuhiro Kida, Kosuke Okuwaki, Hiroshi Yamauchi, Toru Kaneko, Rikiya Hasegawa, Masafumi Watanabe, Takahiro Kurosu, Hiroshi Imaizumi, Wasaburo Koizumi
    Journal of Gastroenterology and Hepatology.2022; 37(6): 1060.     CrossRef
  • Feasibility and Safety of Endoluminal Radiofrequency Ablation as a Rescue Treatment for Bilateral Metal Stent Obstruction Due to Tumor Ingrowth in the Hilum: A Pilot Study
    Hoonsub So, Chi Hyuk Oh, Tae Jun Song, Hyun Woo Lee, Jun Seong Hwang, Sung Woo Ko, Dongwook Oh, Do Hyun Park, Sang Soo Lee, Dong-Wan Seo, Sung Koo Lee, Myung-Hwan Kim
    Journal of Clinical Medicine.2021; 10(5): 952.     CrossRef
  • Fully covered metal biliary stents: A review of the literature
    Robert Lam, Thiruvengadam Muniraj
    World Journal of Gastroenterology.2021; 27(38): 6357.     CrossRef
  • Optimal stent placement strategy for malignant hilar biliary obstruction: a large multicenter parallel study
    Ming-Xing Xia, Xiao-Bo Cai, Yang-Lin Pan, Jun Wu, Dao-Jian Gao, Xin Ye, Tian-Tian Wang, Bing Hu
    Gastrointestinal Endoscopy.2020; 91(5): 1117.     CrossRef
  • Percutaneous stent placement for malignant hilar biliary obstruction: a comparison between criss-cross and T-configuration techniques
    C.H. Jeon, C.J. Yoon, N.J. Seong, H. Lee, J.H. Hwang, J. Kim
    Clinical Radiology.2018; 73(4): 412.e9.     CrossRef
  • Revision of bilateral self-expandable metallic stents placed using the stent-in-stent technique for malignant hilar biliary obstruction
    Jun Hyuk Son, Hee Seung Lee, Sang Hyub Lee, Seungmin Bang, Jinwoo Kang, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim
    Hepatobiliary & Pancreatic Diseases International.2018; 17(5): 437.     CrossRef
  • Placement of a Newly Designed Y-Configured Bilateral Self-Expanding Metallic Stent for Hilar Biliary Obstruction: A Pilot Study
    Dechao Jiao, Kai Huang, Ming Zhu, Gang Wu, Jianzhuang Ren, Yanli Wang, Xinwei Han
    Digestive Diseases and Sciences.2017; 62(1): 253.     CrossRef
  • Simultaneous Versus Sequential Side-by-Side Bilateral Metal Stent Placement for Malignant Hilar Biliary Obstructions
    Tadahisa Inoue, Norimitsu Ishii, Yuji Kobayashi, Rena Kitano, Kazumasa Sakamoto, Tomohiko Ohashi, Yukiomi Nakade, Yoshio Sumida, Kiyoaki Ito, Haruhisa Nakao, Masashi Yoneda
    Digestive Diseases and Sciences.2017; 62(9): 2542.     CrossRef
  • Endoscopic Stents for the Biliary Tree and Pancreas
    Rajesh Krishnamoorthi, Mahendran Jayaraj, Richard Kozarek
    Current Treatment Options in Gastroenterology.2017; 15(3): 397.     CrossRef
  • Comprehensive management of cholangiocarcinoma: Part II. Treatment
    Charilaos Papafragkakis, Jeffrey Lee
    International Journal of Gastrointestinal Intervention.2017; 6(2): 94.     CrossRef
  • Safety and efficacy of transpapillary bridged bilateral side-by-side stenting for unresectable malignant hilar biliary obstruction
    Hirotsugu Maruyama, Kazunari Tominaga, Kunihiro Kato, Satoshi Sugimori, Masatsugu Shiba, Toshio Watanabe, Yasuhiro Fujiwara
    Hepatobiliary & Pancreatic Diseases International.2017; 16(6): 659.     CrossRef
  • Endoscopic reintervention for stent malfunction after stent-in-stent deployment for malignant hilar obstruction
    Joung Boom Hong, Dae Hwan Kang, Hyeong Seok Nam, Cheol Woong Choi, Hyung Wook Kim, Su Bum Park, Su Jin Kim, Woo Hyeok Choi
    Medicine.2017; 96(48): e8867.     CrossRef
  • Congested bile can predict the outcomes of endoscopic stenting for hilar biliary malignancies
    Ming Xing Xia, Bo Sun, Ling Xing, Dao Jian Gao, Xin Ye, Jun Wu, Tian Tian Wang, Bing Hu
    Journal of Digestive Diseases.2017; 18(11): 650.     CrossRef
  • Emerging therapies for the treatment of cholangiocarcinoma
    Sean Turbeville, Carl S. Hornfeldt, Milind Javle, Eric Tran, Marion Schwartz
    International Journal of Hepatobiliary and Pancreatic Diseases.2017; 7(2): 36.     CrossRef
  • Endoscopic management of malignant biliary stenosis. Update and highlights for standard clinical practice
    MªJosé Domper Arnal, Miguel Ángel Simón Marco
    Revista Española de Enfermedades Digestivas.2016;[Epub]     CrossRef
  • Hilar stenting for malignant biliary obstruction
    Shyam Menon
    Gastrointestinal Endoscopy.2016; 83(2): 478.     CrossRef
  • Current Status of Biliary Metal Stents
    Hyeong Seok Nam, Dae Hwan Kang
    Clinical Endoscopy.2016; 49(2): 124.     CrossRef
  • Multiple metallic stents placement for malignant hilar biliary obstruction: Perspective of a radiologist
    Yozo Sato, Yoshitaka Inaba, Kazuo Hara, Hidekazu Yamaura, Mina Kato, Shinichi Murata, Yui Onoda
    International Journal of Gastrointestinal Intervention.2016; 5(1): 52.     CrossRef
  • Feasibility of the placement of a novel 6-mm diameter threaded fully covered self-expandable metal stent for malignant hilar biliary obstructions (with videos)
    Tadahisa Inoue, Fumihiro Okumura, Itaru Naitoh, Shigeki Fukusada, Kenta Kachi, Takanori Ozeki, Kaiki Anbe, Hiroyasu Iwasaki, Takashi Mizushima, Yuji Kobayashi, Norimitsu Ishii, Kiyoaki Ito, Hiromu Kondo, Kazuki Hayashi, Masashi Yoneda, Hitoshi Sano
    Gastrointestinal Endoscopy.2016; 84(2): 352.     CrossRef
  • Diagnosis and endoscopic management of primary sclerosing cholangitis
    Anthony Razzak, Richard Kozarek
    Techniques in Gastrointestinal Endoscopy.2016; 18(3): 158.     CrossRef
  • 8-mm versus 10-mm diameter self-expandable metallic stent in bilateral endoscopic stent-in-stent deployment for malignant hilar biliary obstruction
    Itaru Naitoh, Takahiro Nakazawa, Tesshin Ban, Fumihiro Okumura, Atsuyuki Hirano, Hiroki Takada, Shozo Togawa, Kazuki Hayashi, Katsuyuki Miyabe, Shuya Shimizu, Hiromu Kondo, Yuji Nishi, Michihiro Yoshida, Hiroaki Yamashita, Shuichiro Umemura, Yasuki Hori,
    Journal of Hepato-Biliary-Pancreatic Sciences.2015; 22(5): 396.     CrossRef
  • Outcome of stenting in biliary and pancreatic benign and malignant diseases: A comprehensive review
    Benedetto Mangiavillano
    World Journal of Gastroenterology.2015; 21(30): 9038.     CrossRef
  • International Digestive Endoscopy Network 2014: Turnpike to the Future
    Eun Young Kim, Kwang An Kwon, Il Ju Choi, Ji Kon Ryu, Ki Baik Hahm
    Clinical Endoscopy.2014; 47(5): 371.     CrossRef
  • 8,263 View
  • 131 Download
  • 25 Web of Science
  • 25 Crossref
Close layer
Original Article
Photodynamic Therapy in Unresectable Cholangiocarcinoma: Not for the Uncommitted
Jayant P. Talreja, Marisa DeGaetani, Kristi Ellen, Timothy Schmitt, Monica Gaidhane, Michel Kahaleh
Clin Endosc 2013;46(4):390-394.   Published online July 31, 2013
DOI: https://doi.org/10.5946/ce.2013.46.4.390
AbstractAbstract PDFPubReaderePub
Background/Aims

Photodynamic therapy (PDT) in unresectable cholangiocarcinoma has been associated with improved survival. We report a single tertiary care center experience over the past 6 years.

Methods

Fifty-five patients with unresectable cholangiocarcinoma received PDT between 2004 and 2010. Plastic stents were placed after PDT to prevent cholangitis.

Results

Twenty-seven patients (49%) showed Bismuth type IV, 22 (41%) showed Bismuth type III, and six (10%) showed Bismuth type I and II. Twenty patients (37%) received chemotherapy and radiation therapy, five (9%) received chemotherapy only; and one (2%) received radiation therapy only. Mean number of PDT sessions was 1.9±1.5 sessions (range, 1 to 9). Mean survival duration was 293±266 days (median, 190; range, 25 to 1,332). PDT related complications included three (5%) facial burn, three (5%) photosensitivity, and two (3%) rash. Kaplan-Meier analysis comparing the survival means of patients who received PDT and chemotherapy/radiation therapy (median survival 257 days; 95% confidence interval [CI], 166 to 528) versus who received PDT only (median survival 183 days; 95% CI, 129 to 224) showed no significant difference (log-rank p=0.20).

Conclusions

PDT has a measurable impact on survival in unresectable cholangiocarcinoma but requires aggressive stenting posttherapy.

Citations

Citations to this article as recorded by  
  • Ablation Therapy of the Biliary Tree
    Marina Kim, Darshan Parekh, Michel Kahaleh
    Journal of Clinical Gastroenterology.2024;[Epub]     CrossRef
  • Ablative Therapy in Non-HCC Liver Malignancy
    Tyler P. Robinson, Travis Pebror, Matthew E. Krosin, Leonidas G. Koniaris
    Cancers.2023; 15(4): 1200.     CrossRef
  • Benefits and safety of photodynamic therapy in patients with hilar cholangiocarcinoma: A meta-analysis
    Pengcheng Chen, Ting Yang, Peidong Shi, Jiangbo Shen, Qingchun Feng, Jingen Su
    Photodiagnosis and Photodynamic Therapy.2022; 37: 102712.     CrossRef
  • Photodynamic Therapy (PDT), Radiofrequency Ablation (RFA) With Biliary Stents in Palliative Treatment of Unresectable Extrahepatic Cholangiocarcinoma
    Babu P. Mohan, Saurabh Chandan, Shahab R. Khan, Lena L. Kassab, Suresh Ponnada, Everson L.A. Artifon, Jose P. Otoch, Stephanie McDonough, Douglas G. Adler
    Journal of Clinical Gastroenterology.2022; 56(2): e153.     CrossRef
  • Comparing palliative treatment options for cholangiocarcinoma: photodynamic therapy vs. radiofrequency ablation
    Tayyaba Mohammad, Michel Kahaleh
    Clinical Endoscopy.2022; 55(3): 347.     CrossRef
  • New approach to the treatment of cancer of large duodenal papilla and extrahepatic bile ducts with photodynamic therapy
    E. P. Stranadko, A. V. Baranov, V. A. Duvansky, A. I. Lobakov, V. A. Morokhotov, M. V. Riabov
    Experimental and Clinical Gastroenterology.2022; (5): 78.     CrossRef
  • Endoscopic palliation of malignant biliary obstruction
    Andrew Canakis, Michel Kahaleh
    World Journal of Gastrointestinal Endoscopy.2022; 14(10): 581.     CrossRef
  • Endoscopic Retrograde Cholangiopancreatography-Guided Ablation for Cholangiocarcinoma
    Ross C.D. Buerlein, Andrew Y. Wang
    Gastrointestinal Endoscopy Clinics of North America.2019; 29(2): 351.     CrossRef
  • Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma
    Robert Wentrup, Nicola Winkelmann, Andrey Mitroshkin, Matthias Prager, Winfried Voderholzer, Guido Schachschal, Christian J, rgensen, Carsten B, ning
    Gut and Liver.2016;[Epub]     CrossRef
  • Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis
    Yi Lu, Lei Liu, Jia-chuan Wu, Li-ke Bie, Biao Gong
    Clinics and Research in Hepatology and Gastroenterology.2015; 39(6): 718.     CrossRef
  • Biliary Tumor Ablation with Photodynamic Therapy and Radiofrequency Ablation
    Ioana Smith, Michel Kahaleh
    Gastrointestinal Endoscopy Clinics of North America.2015; 25(4): 793.     CrossRef
  • The Role of Endoscopy in the Diagnosis and Management of Cholangiocarcinoma
    Ajaypal Singh, Uzma D. Siddiqui
    Journal of Clinical Gastroenterology.2015; 49(9): 725.     CrossRef
  • Role of photodynamic therapy and intraductal radiofrequency ablation in cholangiocarcinoma
    Janaki Patel, Nada Rizk, Michel Kahaleh
    Best Practice & Research Clinical Gastroenterology.2015; 29(2): 309.     CrossRef
  • Impact of Radiofrequency Ablation on Malignant Biliary Strictures: Results of a Collaborative Registry
    Reem Z. Sharaiha, Amrita Sethi, Kristen R. Weaver, Tamas A. Gonda, Raj J. Shah, Norio Fukami, Prashant Kedia, Nikhil A. Kumta, Carlos M. Rondon Clavo, Michael D. Saunders, Jorge Cerecedo-Rodriguez, Paola Figueroa Barojas, Jessica L. Widmer, Monica Gaidhan
    Digestive Diseases and Sciences.2015; 60(7): 2164.     CrossRef
  • Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma
    Do Hyun Park, Sang Soo Lee, So Eun Park, Jae Lyun Lee, Jun Ho Choi, Hee Jung Choi, Ji Woong Jang, Hyoung Jung Kim, Jun Bum Eum, Dong-Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Jung Bok Lee
    European Journal of Cancer.2014; 50(7): 1259.     CrossRef
  • Is There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma?
    Arndt Vogel, Oliver Dudeck
    Visceral Medicine.2014; 30(4): 254.     CrossRef
  • 6,787 View
  • 59 Download
  • 16 Crossref
Close layer
Focused Review Series: Photodynamic Therapy
Current Status of Photodynamic Therapy for Bile Duct Cancer
Tae Yoon Lee, Young Koog Cheon, Chan Sup Shim
Clin Endosc 2013;46(1):38-44.   Published online January 31, 2013
DOI: https://doi.org/10.5946/ce.2013.46.1.38
AbstractAbstract PDFPubReaderePub

The most common form in bile duct cancers is a highly desmoplastic cancer with a growth pattern characterized by periductal extension and infiltration. The prognosis of bile duct cancers, especially hilar cholangiocarcinoma, is limited by tumor spread along the biliary tree leading to refractory obstructive cholestasis, cholangitis, and liver failure. Although biliary endoprosthesis improves occlusion rates and reduces the number of therapeutic interventions, median survival time is not ameliorated. Photodynamic therapy (PDT) is a local photochemical tumor treatment that consists of a photosensitizing agent in combination with laser irradiation of a distinct wavelength. Tumor ablation with PDT combined with biliary stenting reduces cholestasis and significantly improves median survival time in selected patients with bile duct cancers.

Citations

Citations to this article as recorded by  
  • The Photosensitizer Temoporfin (mTHPC) – Chemical, Pre‐clinical and Clinical Developments in the Last Decade†‡
    Arno Wiehe, Mathias O. Senge
    Photochemistry and Photobiology.2023; 99(2): 356.     CrossRef
  • Inhibition of hypoxia-inducible factor 1 by acriflavine renders glioblastoma sensitive for photodynamic therapy
    Shuai Ma, Fang Wang, Jiawei Dong, Nan Wang, Shengzhong Tao, Jianyang Du, Shaoshan Hu
    Journal of Photochemistry and Photobiology B: Biology.2022; 234: 112537.     CrossRef
  • Extrahepatic cholangiocarcinoma: Current status of endoscopic approach and additional therapies
    Alina Ioana Tantau, Alina Mandrutiu, Anamaria Pop, Roxana Delia Zaharie, Dana Crisan, Carmen Monica Preda, Marcel Tantau, Voicu Mercea
    World Journal of Hepatology.2021; 13(2): 166.     CrossRef
  • Investigated spectral-fluorescent properties of endogenous porphyrins of the wild boar hepatobiliary system optimize the diagnostics and treatment of cholangiocarcinoma with FD and PDT
    Artem Shiryaev, Polina Alekseeva, Kanamat Efendiev, Dmitry Yakovlev, Arkadii Moskalev, Elizaveta Kozlikina, Pavel Kharnas, Igor Reshetov, Vladimir Levkin, Victor Loschenov
    Optical Engineering.2020; 59(06): 1.     CrossRef
  • New approaches to diagnostics and treatment of cholangiocellular cancer based on photonics methods
    Dmitry V. Yakovlev, Dina S. Farrakhova, Artem A. Shiryaev, Kanamat T. Efendiev, Maxim V. Loschenov, Liana M. Amirkhanova, Dmitry O. Kornev, Vladimir V. Levkin, Igor V. Reshetov, Victor B. Loschenov
    Frontiers of Optoelectronics.2020; 13(4): 352.     CrossRef
  • Therapy for hilar cholangiocarcinoma
    D. Yu. Frantsev, O. N. Sergeeva, B. I. Dolgushin
    Siberian journal of oncology.2019; 18(1): 103.     CrossRef
  • Combined treatment of nonresectable cholangiocarcinoma complicated by obstructive jaundice
    A.A. Shiryaev, G.Kh. Musaev, V.V. Levkin, I.V. Reshetov, M.V. Loshchenov, P.M. Alekseeva, V.V. Volkov, K.G. Linkov, V.I. Makarov, I.O. Shchekoturov, A.V. Borodkin, V.B Loschenov
    Photodiagnosis and Photodynamic Therapy.2019; 26: 218.     CrossRef
  • Local Therapy in Advanced Cholangiocarcinoma: A Review of Current Endoscopic, Medical, and Oncologic Treatment Options
    Carlo Felix Maria Jung, Julie Lavole, Maximilien Barret, Einas Abou Ali, Lola-Jade Palmieri, Solene Dermine, Amélie Barré, Stanislas Chaussade, Romain Coriat
    Oncology.2019; 97(4): 191.     CrossRef
  • Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: A feasibility study
    Luciano Tarantino, Giuseppina Busto, Aurelio Nasto, Riccardo Aurelio Nasto, Paolo Tarantino, Raffaele Fristachi, Luigi Cacace, Sara Bortone
    European Journal of Surgical Oncology.2018; 44(10): 1603.     CrossRef
  • Clinico-pathological factors and prognosis scale for portal cholangiocarcinoma
    Yu. O. Zharikov, Yu. A. Kovalenko, A. A. Olifir, D. V. Kalinin, A. V. Czhao
    Khirurgiya. Zhurnal im. N.I. Pirogova.2017; (1): 27.     CrossRef
  • Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids
    Anne-Laure Bulin, Mans Broekgaarden, Tayyaba Hasan
    Scientific Reports.2017;[Epub]     CrossRef
  • Redox-Responsive Nanophotosensitizer Composed of Chlorin e6-Conjugated Dextran for Photodynamic Treatment of Colon Cancer Cells
    Chong Woo Chu, Je Ho Ryu, Young-IL Jeong, Tae Won Kwak, Hye Lim Lee, Hyun Yul Kim, Gyung Mo Son, Hyung Wook Kim, Dae Hwan Kang
    Journal of Nanomaterials.2016; 2016: 1.     CrossRef
  • Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy
    M. Broekgaarden, R. van Vught, S. Oliveira, R. C. Roovers, P. M. P. van Bergen en Henegouwen, R. J. Pieters, T. M. Van Gulik, E. Breukink, M. Heger
    Nanoscale.2016; 8(12): 6490.     CrossRef
  • Endoscopic management of hilar stricture
    Abhishek Gulati, Payal Thakkar, Shyam Thakkar
    Techniques in Gastrointestinal Endoscopy.2016; 18(2): 67.     CrossRef
  • Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma
    A Schmidt, M Bloechinger, A Weber, J Siveke, S von Delius, C Prinz, W Schmitt, RM Schmid, B Neu
    United European Gastroenterology Journal.2016; 4(4): 570.     CrossRef
  • Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies
    E. Una Cidon
    Clinical Medicine Insights: Oncology.2016; 10: CMO.S32821.     CrossRef
  • Radiological interventions in malignant biliary obstruction
    Kumble Seetharama Madhusudhan, Shivanand Gamanagatti, Deep Narayan Srivastava, Arun Kumar Gupta
    World Journal of Radiology.2016; 8(5): 518.     CrossRef
  • Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy
    Ruud Weijer, Mans Broekgaarden, Massis Krekorian, Lindy K. Alles, Albert C. van Wijk, Claire Mackaaij, Joanne Verheij, Allard C. van der Wal, Thomas M. van Gulik, Gert Storm, Michal Heger
    Oncotarget.2016; 7(3): 3341.     CrossRef
  • Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis
    Yi Lu, Lei Liu, Jia-chuan Wu, Li-ke Bie, Biao Gong
    Clinics and Research in Hepatology and Gastroenterology.2015; 39(6): 718.     CrossRef
  • Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies
    Mans Broekgaarden, Ruud Weijer, Thomas M. van Gulik, Michael R. Hamblin, Michal Heger
    Cancer and Metastasis Reviews.2015; 34(4): 643.     CrossRef
  • Biliary Tumor Ablation with Photodynamic Therapy and Radiofrequency Ablation
    Ioana Smith, Michel Kahaleh
    Gastrointestinal Endoscopy Clinics of North America.2015; 25(4): 793.     CrossRef
  • Nanoparticulate carriers for photodynamic therapy of cholangiocarcinoma: In vitro comparison of various polymer-based nanoparticles
    Jonas Grünebaum, Judith Söbbing, Dennis Mulac, Klaus Langer
    International Journal of Pharmaceutics.2015; 496(2): 942.     CrossRef
  • Improve bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma by cucurbitacin B loaded phospholipid complex modified with berberine hydrochloride
    Ling Cheng, Ping-hua Xu, Bao-de Shen, Gang Shen, Juan-juan Li, Ling Qiu, Chao-yong Liu, Hai-long Yuan, Jin Han
    International Journal of Pharmaceutics.2015; 489(1-2): 148.     CrossRef
  • Role of photodynamic therapy and intraductal radiofrequency ablation in cholangiocarcinoma
    Janaki Patel, Nada Rizk, Michel Kahaleh
    Best Practice & Research Clinical Gastroenterology.2015; 29(2): 309.     CrossRef
  • Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies
    N. Schweitzer, A. Vogel
    Best Practice & Research Clinical Gastroenterology.2015; 29(2): 345.     CrossRef
  • Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells
    Ruud Weijer, Mans Broekgaarden, Rowan F. van Golen, Esther Bulle, Esther Nieuwenhuis, Aldo Jongejan, Perry D. Moerland, Antoine H. C. van Kampen, Thomas M. van Gulik, Michal Heger
    BMC Cancer.2015;[Epub]     CrossRef
  • Endoscopic and Percutaneous Approaches to the Treatment of Biliary Tract and Primary Liver Tumors
    Kevin N. Shah, Bryan M. Clary
    Surgical Oncology Clinics of North America.2014; 23(2): 207.     CrossRef
  • Palliation: Hilar cholangiocarcinoma
    Mahesh Kr Goenka, Usha Goenka
    World Journal of Hepatology.2014; 6(8): 559.     CrossRef
  • Ursodeoxycholic acid-conjugated chitosan for photodynamic treatment of HuCC-T1 human cholangiocarcinoma cells
    Hye Myeong Lee, Young-Il Jeong, Do Hyung Kim, Tae Won Kwak, Chung-Wook Chung, Cy Hyun Kim, Dae Hwan Kang
    International Journal of Pharmaceutics.2013; 454(1): 74.     CrossRef
  • 9,168 View
  • 97 Download
  • 29 Crossref
Close layer
Case Report
One Case of Common Bile Duct Cancer Mimicking Cystic Neoplasm of the Pancreas, Arising 9 Years after Excision of a Choledochal Cyst
Sang Wook Park, Sang Hyub Lee, Young Ook Eum, Hong Sang Oh, Donghyeon Lee, Eunhyo Jin, Kwanghyun Chung, Jin-Hyeok Hwang
Clin Endosc 2012;45(4):435-439.   Published online November 30, 2012
DOI: https://doi.org/10.5946/ce.2012.45.4.435
AbstractAbstract PDFPubReaderePub

A 42-years-old woman had undergone operation for cholecochal cyst with gallbladder cancer 9 years ago. Pathology revealed a polypoid mass in the gallbladder with liver infiltration as poorly differentiated adenocarcinoma. Computed tomography, magnetic resonance cholangiopancreatography, and endoscopic ultrasound showed a newly developed suspected solid nodule in the peripheral portion of cystic lesion in the pancreas head. She underwent a pylorus preserving pancreaticoduodenectomy for the suspected mucinous cystic neoplasm of the pancreas. Pathology revealed poorly differentiated adenocarcinoma. The remnant choledochal cyst had developed to cholangiocarcinoma, which mimicked cystic neoplasm of the pancreas.

Citations

Citations to this article as recorded by  
  • Carcinoma of the Papilla of Vater after Diversion Operation for Pancreaticobiliary Maljunction
    Takahiro Yamanaka, Kenichiro Araki, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Hiroyuki Kuwano, Ken Shirabe
    Case Reports in Gastroenterology.2017; 11(2): 265.     CrossRef
  • Treatment and outcomes of adults with remnant intrapancreatic choledochal cysts
    Hong-Tian Xia, Tao Yang, Bin Liang, Jian-Ping Zeng, Jia-Hong Dong
    Surgery.2016; 159(2): 418.     CrossRef
  • 6,040 View
  • 46 Download
  • 2 Crossref
Close layer
Special Issue Articles of IDEN 2012
Usefulness of Intraductal Ultrasonography in the Diagnosis of Cholangiocarcinoma and IgG4-Related Sclerosing Cholangitis
Takahiro Nakazawa, Itaru Naitoh, Kazuki Hayashi
Clin Endosc 2012;45(3):331-336.   Published online August 22, 2012
DOI: https://doi.org/10.5946/ce.2012.45.3.331
AbstractAbstract PDFPubReaderePub

The technique of intraductal ultrasonography (IDUS) of the bile duct with a thin-caliber probe and a ropeway system has provided excellent images of the bile duct and periductal structures and is an easy transpapillary approach. In addition, once the guide wire is inserted into the bile duct, IDUS and transpapillary biopsy after endoscopic retrograde cholangiopancreatography can be performed in a single session. Here, we review the usefulness of IDUS in the diagnosis of cholangiocarcinoma and IgG4-related sclerosing cholangitis.

Citations

Citations to this article as recorded by  
  • Mimickers of immunoglobulin G4-related hepatobiliary disease on biopsy
    Byoung Uk Park, Hee Eun Lee, Lizhi Zhang
    Seminars in Diagnostic Pathology.2024; 41(2): 95.     CrossRef
  • IgG4-related sclerosing cholangitis overlapping with autoimmune hepatitis: Report of a case
    Hongyan Li, Li Sun, David R. Brigstock, Lina Qi, Runping Gao
    Pathology - Research and Practice.2017; 213(5): 565.     CrossRef
  • Percutaneous transluminal forceps biopsy in patients suspected of having malignant biliary obstruction: factors influencing the outcomes of 271 patients
    Jung Gu Park, Gyoo-Sik Jung, Jong Hyouk Yun, Byung Chul Yun, Sang Uk Lee, Byung Hoon Han, Ji Ho Ko
    European Radiology.2017; 27(10): 4291.     CrossRef
  • IgG4-related sclerosing cholangitis and chronic sclerosing sialadenitis mimicking cholangiocarcinoma and neck malignancy
    Li Sun, Hong-Yan Li, David R Brigstock, Run-Ping Gao
    Hepatobiliary & Pancreatic Diseases International.2017; 16(4): 443.     CrossRef
  • Two cases of immunoglobulin G4-related sclerosing cholangitis in which transabdominal ultrasonography was useful in diagnosis and follow-up observation
    Ikuhiro Kobori, Toshikuni Suda, Akihiro Nakamoto, Hiroki Saito, Osamu Okawa, Rion Sudo, Yoshinori Gyotoku, Yasumi Katayama, Masaya Tamano
    Journal of Medical Ultrasonics.2016; 43(2): 271.     CrossRef
  • IgG4-related hepatobiliary disease: an overview
    Emma L. Culver, Roger W. Chapman
    Nature Reviews Gastroenterology & Hepatology.2016; 13(10): 601.     CrossRef
  • UEG Week 2016 Oral Presentations

    United European Gastroenterology Journal.2016; 4(5_suppl): A1.     CrossRef
  • Immunoglobulin G4–Related Sclerosing Cholangitis Mimicking Hilar Cholangiocarcinoma Diagnosed With Following Bile Duct Resection: Report of a Case
    Atsushi Miki, Yasunaru Sakuma, Hideyuki Ohzawa, Yukihiro Sanada, Hideki Sasanuma, Alan T. Lefor, Naohiro Sata, Yoshikazu Yasuda
    International Surgery.2015; 100(3): 480.     CrossRef
  • Endoscopic diagnosis of cholangiocarcinoma: From endoscopic retrograde cholangiography to bile proteomics
    Torsten Voigtländer, Tim O. Lankisch
    Best Practice & Research Clinical Gastroenterology.2015; 29(2): 267.     CrossRef
  • 7,492 View
  • 85 Download
  • 9 Crossref
Close layer
The Long-term Outcome and Predictors for Increased Survival after PDT for Hilar Cholangiocarcinoma
Ji Ho Ahn, M.D., Young Koog Cheon, M.D., Young Deok Cho, M.D., Hyun Jong Choi, M.D., Jong Ho Moon, M.D., Tae Hoon Lee, M.D., Sang Heum Park, M.D. and Chan Sup Shim, M.D.*
Korean J Gastrointest Endosc 2011;42(1):6-10.   Published online January 30, 2011
AbstractAbstract PDF
Background/Aims: Photodynamic therapy (PDT) has a promising effect on nonresectable cholangiocarcinoma (CC) but its long term data is not yet available. This study examined the long term outcome and factors associated with increased survival after performing PDT for hilar cholangiocarcinoma.

Methods: A list of 393 patients with a diagnosis of hilar CC was retrieved from the database of Soonchunhyang University Hospital (Seoul, Korea) and these patients were seen from January 1, 2001, to April 1, 2010. We retrospectively reviewed the records of 74 patients who underwent PDT in addition to biliary stenting with/without chemoradiation.

Results: The median overall survival from the date of diagnosis to death or to the last follow-up was 11.7 months (range: 2.2∼78.4). After performing PDT, a complete remission was observed in 1.3% (1/74) of the patients who had a superficial depth of tumor without lymph node involvement. On multivariate analysis using the Cox regression model, increasing the time to treatment after the diagnosis was a statistically significant predictor of shorter survival after PDT [Odds ratio: 3.25, 95% confidence interval (CI): 1.90∼4.71, p=0.034].

Conclusions: Although PDT does not prevent progression of CC, it appears to control the cholestasis. The early treatment of PDT after the diagnosis showed a survival benefit for patients with advanced hilar CC. (Korean J Gastrointest Endosc 2011;42:6-10)

  • 1,750 View
  • 14 Download
Close layer
A Preliminary Study on the Usefullness of a Zilver Stent for Bilateral Stenting in Patients with Advanced Hilar Cholangiocarcinoma
Jae Sup Eum, M.D., Dae Hwan Kang, M.D. and Cheol Woong Choi, M.D.
Korean J Gastrointest Endosc 2008;36(6):354-360.   Published online June 30, 2008
AbstractAbstract PDF
Background
/Aims: Hilar cholangiocarcinomas have an extremely poor prognosis. Although endoscopic bilateral metal stenting with the "stent in stent" technique using a Y stent is currently employed to treat patients with an unresectable hilar cholangiocarcinoma, this method has limited application in cases of tight strictures. Furthermore, insertion of stents into the Y stent side (first stent side) is problematic in cases of tumor recurrence. We evaluated the clinical efficacy of the use of endoscopic bilateral metal stenting with the Zilver stent. Methods: Seven patients with an unresectable Bismuth type III or IV hilar cholangiocarcinoma were included in this study. For endoscopic bilateral metal stenting, we first inserted a Y stent with a central wide-open mesh. The Zilver stent was placed into the contralateral hepatic duct through the central portion of the Y stent. Results: Both technical and functional success was achieved in seven patients (100%). The early complication rate was 0%, and late complications due to tumor recurrence occurred in 2 out of 7 (28.6%) patients. These patients were managed by the placement of additional stents or with the use of percutaneous transhepatic biliary drainage. Conclusions: We suggest that a combination technique using Y and Zilver stents improves bilateral stenting for patients with advanced hilar cholangiocarcinoma and facilitates stent reinsertion in cases of tumor recurrence. (Korean J Gastrointest Endosc 2008; 36:354-360)
  • 1,948 View
  • 5 Download
Close layer
Endoscopic Bilateral Metal Stent Placement with a Y-Configured Dual Stent for Advanced Hilar Carcinoma
Jong Ho Hwang, M.D.*, Dae Hwan Kang, M.D., Sang Yong Lee, M.D.*, Kyung Yeob Kim, M.D., Jae Sup Eum, M.D., Ji Young Kim, M.D., Do Hoon Kim, M.D., Gwang Ha Kim, M.D., Jeong Heo, M.D., Geun Am Song, M.D. and Mong Cho, M.D.
Korean J Gastrointest Endosc 2008;36(1):7-13.   Published online January 30, 2008
AbstractAbstract PDF
Background
/Aims: Palliative endoscopic or percutaneous internal drainage is widely used for treating hilar cholangiocarcinoma. Yet unilateral biliary drainage does not completely improve jaundice and it can induce acute cholangitis by the undrained contrast media. To investigate this technique's technical and clinical effectiveness, a newly devised Y-configured dual stent was used for treating advanced hilar malignancies. Methods: From May, 2005 to May, 2007, 20 hilar malignancies (men: women=9:11, age=70.5 yr) that were not suitable for surgical resection were included in this study. For bilateral metal stent placement, a biliary stent with a wide open central mesh was first inserted. After this, another stent without a hole was inserted into the contralateral hepatic duct through the open central mesh of the first stent. Results: Bilateral metal stent insertion was done in 14 of 20 patients. Among the 14 patients in whom bilateral stents were successfully placed, the rate of functional success was 100%. There were no early complications. As a late complication, stent occlusion occurred in 4 of 14 patients (28.5%), and one of these patients had a plastic stent inserted. The other 3 patients were treated with percutaneous transhepatic biliary drainage. The median stent patency period was 231 days. Conclusions: The bilateral metal stent method using the Y stent is safe and effective for bilateral biliary drainage in patients with unresectable hilar malignancies. (Korean J Gastrointest Endosc 2008;36:7-13)
  • 1,746 View
  • 7 Download
Close layer
The Clinical Efficacy of Percutaneous Bilateral Internal Drainage in Advanced Hilar Malignancy by T-Configured Dual Stent Placement: Comparison with Unilateral Endoscopic Stent Placement
Joo Ho Lee, M.D., Sang Yong Lee, M.D., Jung Hyun Lee, M.D., Hyo Jin Jung, M.D., Tae Oh Kim, M.D., Gwang Ha Kim, M.D., Jeong Heo, M.D., Dae Hwan Kang, M.D., Geun Am Song, M.D., Mong Cho, M.D., Suk Kim, M.D.*, Chang Won Kim, M.D.* and Suk Hong Lee, M.D.*
Korean J Gastrointest Endosc 2006;33(2):85-93.   Published online August 30, 2006
AbstractAbstract PDF
Background
/Aims: Endoscopic or percutaneous internal drainage is a well-established palliative treatment for unresectable biliary tumors. Previous studies dealing with the unilateral versus bilateral liver lobe drainage have reported inconsistent results. This study evaluated the clinical efficacy of bilateral drainage with a newly designed T configured dual stent (T-stent) placement. Methods: From 2001 to 2004, 46 hilar malignancies, which were not suitable for endoscopic retrograde biliary drainage (ERBD) on MR cholangiography were treated with the percutaneous placement of two self-expandable metallic endoprostheses in a T configuration through a single transhepatic access. The outcomes were examined retrospectively. The hilar malignancies, which were drained by unilateral ERBD were also reviewed. Results: The 46 hilar malignancies drained by a T stent included a cholangiocarcinoma (n=36), gallbladder cancer (n=6), and metastatic cancer (n=4). Procedure related cholangitis occurred in 3 out of 46 patients (6.5%). The mean survival and stent patency times were 256 and 194 days, respectively. The 34 hilar malignancies drained by unilateral ERBD included cholangiocarcinoma (n=29), gallbladder cancer (n=3), and pancreatic cancer (n=2). Procedure related cholangitis occurred in 7 out of 34 patients (20.6%). The mean survival and stent patency times were 292 and 186 days, respectively. There were no statistically significant differences in the cholangitis frequency, survival and stent patency between the two groups. The frequency of cholangitis, mean survival and patency time in Klatskin tumors, which were drained by the T-stent (n=36) and ERBD (n=29), were compared. There were no significant differences in survival and stent patency time. Conclusions: T-configured dual stent placement can be used effectively in advanced biliary hilar malignancies. It can be used as a safe palliative drainage method in advanced hilar tumors, which are not suitable for ERBD. (Korean J Gastrointest Endosc 2006;33:85⁣93)
  • 1,730 View
  • 5 Download
Close layer
A Case of Clonorchiasis Presenting as Common Hepatic Duct Mass
Choul Woong Hwang, M.D., Byung Wook Lim, M.D., Ung Ryu, M.D., Jong Hoon Kim, M.D., Hye Yeon Park, M.D., Kyung Il Park, M.D., Sung Moon Jung, M.D., Kyung-Ah Kim, M.D., Jeon Ho Yang, M.D., June Sung Lee, M.D., Young Soo Moon, M.D., Young Bin Jeon, M.D.*, Sa
Korean J Gastrointest Endosc 2005;31(4):268-272.   Published online October 30, 2005
AbstractAbstract PDF
The liver fluke, Clonorchis sinensis is an important human parasite and is endemic in Eastern Asia including Korea, China, and Japan. Patients acquire the infestation by eating raw or undercooked freshwater fish. Radiologic examinations usually reveal dilated peripheral intrahepatic bile ducts and normal extrahepatic bile duct. The diagnosis of clonorchiasis may sometimes be difficult and a presentation as an obstructive mass at the common hepatic duct is a rare event. Here we report a case of clonorchiasis of 54-year- old woman presented with epigastric pain. Endoscopic retrograde cholangiography revealed a mass at the common hepatic duct with dilatation of the intrahepatic ducts mimicking cholangiocarcinoma. Using an endoscopic basket, muddy, sludge-like materials were extracted through the papillary orifice. We report this case with a review of literatures. (Korean J Gastrointest Endosc 2005;31:268⁣272)
  • 2,154 View
  • 4 Download
Close layer
구연 / 담췌 : 58 세 남자 , 황달
Korean J Gastrointest Endosc 2001;22(5):321-322.   Published online November 30, 2000
PDF
  • 1,519 View
  • 0 Download
Close layer
간문부 담관암의 담도내 종적 침윤 평가에 있어 자기공명 담관조영술과 경피경간 담도경 성적의 비교
Korean J Gastrointest Endosc 2001;23(5):318-318.   Published online November 30, 2000
PDF
  • 1,424 View
  • 1 Download
Close layer
Mucin-hypersecreting Cholangiocarcinoma
Korean J Gastrointest Endosc 2000;20(5):411-411.   Published online November 30, 1999
PDF
  • 1,042 View
  • 2 Download
Close layer
췌장의 점액 생산성 종양과 유사한 점액 생산성 담도암 8예 ( Eight Cases of Mucin-hypersecreting Cholangiocarcinoma Similar to Intraductal Papillary Mucinous Tumor of the Pancreas )
Korean J Gastrointest Endosc 2000;20(1):33-40.   Published online November 30, 1999
AbstractAbstract PDF
Background
/Aims: Mucin-hypersecreting cholangiocarcinoma is very similar to intraductal papillary mucinous tumor (IPMT) of the pancreas. But this disease is rare and its clinicopathologic features are not well known. The purposes of this study are to report our experience of eight patients with the tumor and to analyze the characteristics of its clinical, radiological and pathological finding. Methods: Eight patients (3 men and 5 women, mean age 52 years) were diagnosed as having a mucin-hypersecreting cholangiocarcinoma among 4,570 cases of ERCP from 1995 to 1998. Results: Recent or previous attacks of biliary pain or acute cholangitis were elicited in most of the patients. CT showed diffuse intra- and extra-hepatic duct dilatation in all patients and suspicious ill-defined mass shadow in 2 out of 8 patients. On cholangioscopic examination, a papillary mass or minute mucosal lesion was found in the dilated bile duct containing thick viscid mucin. Eight patients were recommended an operation and curative resection was performed in seven patients. Histologically, well-differentiated adenocarcinoma in the background of benign hyperplasia and adenoma was documented in all patients. Conclusions: Mucin- hypersecreting cholangiocarcinoma may be characterized by exceedingly similarity to IMPT of the pancreas in clinical, radiological and pathological features. Further investigation is needed for detailed information such as natural history and outcome. (Korean J Gastrointest Endosc 2000;20:33~40)
  • 1,388 View
  • 2 Download
Close layer
경피경간 담도배액관을 따라 피부로 전이된 담도암 1예 ( Subcutaneous Implantation Metastasis of a Cholangiocarcinoma of the Bile Duct after Percutaneous Transhepatic Biliary Drainage (PTBD) )
Korean J Gastrointest Endosc 1999;19(5):837-842.   Published online November 30, 1998
AbstractAbstract PDF
Percutaneous transhepatic biliary catheterization (PTC) has not only been increasingly used in the localization of benign and malignant lesions, but it is also considered rapid, safe and effective method to establish internal and external drainage for decompression of biliary obstructions. Infections and granulomas at the catheter entry site can occasionally develop, but are easily managed. However, such technique, when used both for obtaining malignant cells for diagnosis and for percutaneous decompression of the biliary tract can exposure the patient at risk for dissemination of the tumor along the catheter tract. This rare complication has been observed in a patient who underwent percutaneous transhepatic biliary drainage (PTBD) for malignant biliary tract obstruction. Although tumor cell seeding along the catheter tract is a very rare complication, we think that PTBD should be avoided when curative resection is planned. (Korean J Gastrointest Endosc 19: 837∼842, 1999)
  • 1,663 View
  • 1 Download
Close layer
직장 자궁내막증: 증례보고 및 국내문헌 고찰 ( Rectal Endometriosis: A Case Report of with a Clinical Analysis of Other Cases Reported in Related Korean Literature )
Korean J Gastrointest Endosc 1999;19(4):667-674.   Published online November 30, 1998
AbstractAbstract PDF
Hemobilia is defined as a hemorrhage in the biliary tract and is most commonly associated with accidental or iatrogenic trauma. A case is herein reported of hemobilia developed in a hepatic artery aneurysm after biliary stenting was performed in patient with cholangiocarcinoma. A 63-year-old man was admitted with melena and had history of cholangiocarcinoma with an intraductal biliary stent. A hepatic artery angiography revealed two pseudoaneurysms at the common hepatic artery and right hepatic artery. Transarterial embolization with gelfoam was successfully received and hemobilia was not developed later. (Korean J Gastrointest Endosc 19: 671∼675, 1999)
  • 1,456 View
  • 2 Download
Close layer
증례 : 식도 위장관 ; 간내 담석이 위치한 부위와 다른 부위에 병발된 간내 담관암 1예 ( Case Reports : Esophagus , Stomach & Intestine ; A Case of Intrahepatic Cholangiocarcinoma Developed in a Remote Region from the Site of Hepatolithiasis )
Korean J Gastrointest Endosc 1998;18(6):968-975.   Published online November 30, 1997
AbstractAbstract PDF
An association of hepatolithiasis and cholangiocarcinoma is thought to be rare, with a rate reported to be 2.36%-10%. Most of the cholangiocarcinomas concurrent with intrahepatic stones are found in the vicinity of the hepatolithiasis, and the diagnosis of intrahepatic cholangiocarcinoma in cases with hepatolithiasis is very difficult to detect preoperatively in spite of recent developments in techniques of imaging studies. Recently, the development of cholangiocarcinoma was reportd even after the complete removal of the hepatic stones. Thus, bile stasis and bacterial infecton appear to be important causative factors causing cholangiocarcinoma rather than the stone itself. A rare case is reported on intrahepatic cholangiocarcinoma developed in a remote region from the site of the hepatolithiasis. Therefore, the possible presence of cholangiocarcinoma should always be considered and sought during the diagnosis and treatment of hepatolithiasis. (Korean J Gastrointest Endosc 18: 968-973, 1998)
  • 1,363 View
  • 0 Download
Close layer
증례 : 식도 위장관 ; 반복적인 담관염으로 나타난 점액 생성 담관암 1예 ( Case Reports : Esophagus , Stomach & Intestine ; A Case of Mucin - producing Cholangiocarcinoma in the Patient with Recurrent Cholangitis )
Korean J Gastrointest Endosc 1998;18(6):957-962.   Published online November 30, 1997
AbstractAbstract PDF
Free-floating tumor debris or mucobilia as a cauae of intermittent obstruction has been described infrequently. A middle aged woman with intermittent jaundice caused by abundant mucus from an intrahepatic mucinous cholangiocarcinoma is presented. Symptoms of juandice, midepigastric pain and fever developed despited an intitial cholecystectomy and common bile duct stone extraction using endoscopic retrograde cholangography (ERCP). Intraductal mucin was diagnosed through on ERCP and confirmed intraoperatively and pathologically as the cause of the obstructive juandice. The patient remained asymptomatic and without evidence of disease for more than 2 years postoperatively. Description is presented of the patient who was admitted presented with recurrent cholangitis caused by profuse secretion of mucus by mucin-producing cholangiocaricnoma, with a review of relevant literature. (Korean J Gastrointest Endosc 18: 957-962, 1998)
  • 1,485 View
  • 4 Download
Close layer
증례 : 담도 췌장 ; 담낭관의 하부접합과 연관된 원발성 중복종양 1예 ( Case Reports : Biliary Tract & Pancreas ; A Case of Double Primary Cancer Associated with a Low Junction of the Cystic Duct )
Korean J Gastrointest Endosc 1998;18(4):630-636.   Published online November 30, 1997
AbstractAbstract PDF
Recently it has been discovered that anomalous union of pancreaticobiliary duct (AUPBD) may play an important role in the pathogenesis of bile duct cancer. Similar to this fact, there were a few reports on the clinical significance of the low junction of the cystic duct (LJCD). LJCD refers to the situation whereby the cystic duct enters the common duct at a low position between the upper margin of the pancreas and the duodenal opening of the bile duct. The pathogenetic mechanism in LJCD is similar to AUPBD in that the pancreatic juice refluxes to the bile duct, mixes with biles, and then generates the mutagens, which act as inflammatory substances and carcinogens on the epithelium of the bile duct. A 51-year-old male who experienced dyspepsia was hospitalized due to his abnormally functioning liver and dilated common bile duct. We confirmed primary cholangiocarcinoma on the common hepatic duct and gallbladder carcinoma associated with LJCD by ERCP and pathologic review of surgical specimen. We report a case of synchronous type double primary cancer associated with LJCD with a brief review of the literatures. (Korean J Gastrointest Endosc 18: 630-636, 1997)
  • 1,400 View
  • 2 Download
Close layer
증례 : 담도 췌장 ; 담관 점막 및 점막하를 따라 담낭 및 총간관으로 전이된 총 담관암 1예 ( Case Reports : Biliary Tract & Pancreas ; A Case of Common Bile Duct Cancer with Mucosal and Submucosal Spread to Gallbladder and Common Hepatic Duct )
Korean J Gastrointest Endosc 1997;17(6):872-877.   Published online November 30, 1996
AbstractAbstract PDF
Cholangiocarcinoma is a form of adenocarcinoma arising from the intrahepatic or extra- hepatic biliary epithelium. Apparent predisposing factors include some chronic hepato- biliary parasitic infsttations, congenital anomalies with ectatic ducts, sclerosing cholangitis and chronic ulcerative colitis and occupational exposure to possible biliary tract carcinogens. Patients with cholangiocarcinoma usually present with biliary obstruction, painless jaundice, pruritus, weight loss and acholic stools. Because the obstructing process is gradua1, the cholangiocarcinoma is often far advanced by the time it presents clinically. The diagnosis is most frequently made by cholangiography following ultrasound demonstration of dilated intrahepatic bile ducts. We report a case of common bile duct cancer spreading to gallbladder and common hepatic duct along the biliary mucosal epitherium and submucosal tissue in 68-year-old female patient along with a review of literature. (Korean J Gastrointest Endosc 17: 872-877, 1997)
  • 1,324 View
  • 1 Download
Close layer
증례 : 담도 췌장 ; 원발성 경화성 담관염에서 발생했다고 추정되는 담관암종 1예 ( Case Reports : Biliary Tract & Pancreas ; A Case of Cholangiocarcinoma Suggested as Developing in the Patient with Primary Sclerosing Cholangitis )
Korean J Gastrointest Endosc 1997;17(1):99-104.   Published online November 30, 1996
AbstractAbstract PDF
Primary sclerosing cholangitis is a chronic disease of unknown cause, characterized by inflammation and fibrosis of the biliary tree with diffuse multifocal stricture formation. With increasing knowledge of primary sclerosing cholangitis, it is now recognized that in the setting of inflammatory bowel disease, cholangiocarcinoma is a complication of primary sclerosing cholangitis. We recently experienced a case of 41 year old female patient who had Crohns disease associated with primary sclerosing cholangitis and cholangioearcinoma. We report a case of primary sclerosing cholangitis with cholangiocarcinoma with literature review. (Korean J Gastrointest Endosc 17: 99~104, 1997)
  • 1,278 View
  • 0 Download
Close layer

Close layer
TOP